dextrothyroxine has been researched along with Elephantiasis, Filarial in 263 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (2.66) | 18.7374 |
| 1990's | 44 (16.73) | 18.2507 |
| 2000's | 62 (23.57) | 29.6817 |
| 2010's | 91 (34.60) | 24.3611 |
| 2020's | 59 (22.43) | 2.80 |
| Authors | Studies |
|---|---|
| Alexandre, JS; Burgert-Brucker, CR; Clementson, N; Cox, H; Dilliott, D; Harding-Esch, EM; Krentel, A; Morice Trejos, AC; Niles, RA; Sampson, A; Scholte, RGC; Thickstun, CR | 1 |
| Bolay, FK; Eneanya, OA; Fischer, PU; Gankpala, L; Goss, CW; Weil, GJ | 1 |
| Gasarasi, DB; Lupenza, ET; Minzi, OM | 1 |
| Abd-Elsalam, S; Abdelazeem, B; Abuelazm, MT; Ashraf, M; Badr, H; Gamal, M | 1 |
| Carvalho, N; Engelman, D; Kado, J; Kaldor, J; Kama, M; Mani, J; Mow, M; Parnaby, M; Rafai, E; Romani, L; Sahukhan, A; Steer, A; Thean, LJ; Tuicakau, M; Whitfeld, M | 1 |
| Amuga, M; Bieb, S; Bjerum, C; Goss, CW; Howard, C; John, LN; Karl, S; Kerry, Z; King, CL; Kotty, B; Kualawi, M; Kumai, S; Laman, M; Lorry, L; Makita, L; O'Brian, K; Pomat, W; Robinson, LJ; Samuel, A; Tavul, L; Tisch, DJ; Wangi, J; Weil, GJ | 1 |
| Ghosh, RS; Haldar, P; Jacobson, J | 1 |
| Jacobson, J; King, JD; Krentel, A | 1 |
| Bechu, V; Bhagirov, R; Brant, TA; Buhagiar, TS; Camacho, J; Chutaro, E; Dodd, E; Faktaufon, D; Hardy, M; Kaldor, J; Lepaitai, HB; Mani, J; Naqio, F; Naseri, T; Nua, MT; Otaki, J; Padmasiri, E; Rainima-Qaniuci, M; Romani, L; Samuela, J; Sekihara, M; Sosene, V; Steer, AC; Suiaunoa-Scanlan, L; Thean, LJ; Thomsen, R; Tufa, A; Utu, F; Won, KY; Yajima, A | 1 |
| Dhingra, N; Roy, N; Tripathi, B | 1 |
| Dubray, C; Fayette, C; Fischer, P; Hardy, M; Jambulingam, P; King, C; Krishnamoorthy, K; Laman, M; Lemoine, JF; Samuela, J; Subramanian, S; Supali, T; Weil, GJ | 1 |
| Fischer, PU; Krentel, A; Weil, GJ | 1 |
| Jacobson, J | 1 |
| Bolay, FK; Curtis, K; Eneanya, OA; Fischer, K; Fischer, PU; Gankpala, L; Goss, CW; Gray, EB; Momolu, AT; Nyan, ES; Weil, GJ | 1 |
| Albert, JM; Bieb, S; Bjerum, CM; Howard, SC; John, L; Karl, S; Kerry, Z; King, CL; Kotty, B; Kumai, S; Laman, M; Lorry, L; Makita, L; Payne, M; Robinson, LJ; Samuel, A; Tavul, L; Timinao, L; Tisch, DJ; Wangi, J; Weil, GJ | 1 |
| Gayen, S; Jana, JK; Mandal, AK; Pal, AC | 1 |
| Abubakar Umar, Z; Amazigo, UV; Anagbogu, IN; Barbre, K; Davies, E; Ekpo, UF; Gideon Nteun, U; Igbe, M; Jacob, SM; Nyior, A; Okoronkwo, C; Oyale, P; Saka, YA; Surakat, OA | 1 |
| Glass, K; Graves, PM; Lau, C; McLure, A; Shaw, C | 1 |
| Chachage, M; Chiwerengo, N; Clowes, P; Debrah, A; Geldmacher, C; Haule, A; Hoelscher, M; Hoerauf, A; Horn, S; Kalinga, A; Kavishe, G; Kroidl, I; Lazarus, W; Maganga, L; Marandu, TF; Mhidze, J; Mnkai, J; Mosoba, M; Ngenya, A; Ntapara, E; Rieß, F; Saathoff, E; Urio, A | 1 |
| Bockarie, MJ; Coulibaly, ME; Coulibaly, SY; Coulibaly, YI; Dembele, M; Diabaté, AF; Diallo, AA; Diarra, L; Dicko, I; Dolo, H; Doumbia, SS; Kelly-Hope, LA; Klion, AD; Koudou, BG; Nutman, TB; Sangare, M; Soumaoro, L | 1 |
| Bolay, FK; Caja Rivera, RM; Coffeng, LE; de Vlas, SJ; Eneanya, OA; Fischer, PU; Hollingsworth, TD; Koudou, BG; Méité, A; Michael, E; Prada, JM; Sharma, S; Stolk, WA; Touloupou, P; Weil, GJ | 1 |
| Bougma, R; Bougouma, C; Guire, I; Kabre, C; Kima, A; Nare, D; Nassa, C; Ouedraogo, M; Serme, M; Zida, A; Zoromé, H | 1 |
| Doe, F; Dubben, B; Fetcho, N; Fischer, K; Fischer, PU; Gordor, S; Goss, CW; Gyasi, ME; Hoerauf, A; Hong, AR; Kanza, E; King, CL; Laryea, R; Lew, D; Opoku, NO; Seidu, MA; Weil, GJ | 1 |
| Alshehri, A; Bala, V; Bjerum, CM; Chhonker, YS; Edi, C; John, LN; King, CL; Koudou, BG; Marks, M; Mitjà, O; Murry, DJ | 1 |
| Gebre, T; Mabey, DCW; Marks, M; McPherson, S; Seife, F; Solomon, AW; Solomon, H | 1 |
| Aklillu, E; Barry, A; Guantai, A; Khaemba, C; Kirui, E; Njenga, SM; Oluka, M; Omondi, WP; Parthasarathi, G | 1 |
| David, MC; Engelman, D; Graves, PM; Kearns, T; Lau, CL; Mayfield, HJ; Naseri, T; Sheridan, S; Steer, AC; Thomsen, R; Willis, GA | 1 |
| Alshehri, A; Bala, V; Bjerum, C; Budge, PJ; Chhonker, YS; Fischer, PU; Gabo, TP; King, CL; Koudou, BG; Meïté, A; Murry, DJ; Ouattara, AF; Weil, GJ | 1 |
| Asmare, T; Bekele, F; Birhanu, H; Endeshaw, T; Griswold, E; Hassen, M; Katabarwa, M; Meribo, K; Mohammed, A; Noland, GS; Richards, F; Samuel, F; Seid, T; Seife, F; Tadesse, Z; Tamiru, M; Yayeh, A | 1 |
| Bjerum, CM; Budge, PJ; Fischer, PU; Gabo, PT; Goss, CW; King, CL; Koudou, BG; Lew, D; Ouattara, AF; Weil, GJ | 1 |
| Downs, P; Jeyam, A; Kebede, F; Selby, R; Tate, A | 1 |
| Bisanzio, D; Bisoffi, Z; Buonfrate, D; Montresor, A; Tamarozzi, F | 1 |
| Alomatu, B; Asiedu, O; Biritwum, NK; Boakye, DA; de Vlas, SJ; Frempong, KK; Gyapong, JO; Hervie, ET; Kontoroupis, P; Marfo, B; Odoom, S; Stolk, WA; Verver, S; Yeboah, A | 1 |
| Chami, GF; Kabatereine, NB; Tukahebwa, EM | 1 |
| Andersen, BJ; Curtis, K; Fischer, PU; Hertz, MI; King, CL; Kupritz, J; Meite, A; Mitreva, M; Rosa, BA; Serge, T; Weil, GJ | 1 |
| Aboulaye, M; Andersen, BJ; Bjerum, CM; King, CL; Kouadio, O; Koudou, BG; Marius, VK; Ouattara, AF; Weil, GJ | 1 |
| Krishnamoorthy, K; Kuttiatt, VS; Purushothaman, J; Somani, RK; Swaminathan, S; Weil, GJ | 1 |
| Baker, M; Bisanzio, D; Chowdhury, D; Conteh, A; Hodges, MH; Kamara, W; Koroma, JB; Macarthy, F; Magbity, E; Samai, M; Sonnie, M; Toubali, EH; Zoerhoff, KL | 1 |
| Colebunders, R; Coulibaly, ME; Coulibaly, SY; Coulibaly, YI; Diallo, AA; Diarra, Y; Dolo, H; Doumbia, S; Doumbia, SS; Konipo, FN; Nutman, TB; Sangare, M; Sangare, MB; Soumaoro, L | 1 |
| Evans, DS | 1 |
| Grobler, AC; Hardy, M; Kaldor, JM; Kama, M; King, CL; Robinson, LJ; Romani, L; Samuela, J; Steer, AC; Tuicakau, M; Weil, GJ; Whitfeld, MJ | 2 |
| Basáñez, MG; Colebunders, R; Coulibaly, ME; Coulibaly, SY; Coulibaly, YI; Dembélé, M; Diallo, AA; Diarra, D; Dicko, I; Dolo, H; Doumbia, SS; Nutman, TB; Sangare, MB; Soumaoro, L; Sow, M; Walker, M | 1 |
| Adelamo, SE; Anagbogu, I; Danboyi, J; Davies, E; Eigege, A; Kadimbo, JA; Mancha, BS; Miri, ES; Noland, GS; Nwodu, K; Richards, FO; Saka, YA; Sallau, A; Umaru, J | 1 |
| Abong, RA; Akame, J; Amambo, G; Beng, AA; Biholong, B; Deribe, K; Enyong, PI; Esum, ME; Fombad, FF; Fru, J; Gandjui, NTV; Mbia, P; Nchanji, GT; Ndongmo, PWC; Njouendou, AJ; Nko'Ayissi, G; Reid, SD; Tougoue, JJ; Wanji, S; Zhang, Y | 1 |
| Kazura, JW; King, CL; Weil, GJ | 1 |
| Basáñez, MG; Hamley, JID; Milton, P; Monnot, F; Pedrique, B; Walker, M | 1 |
| Beau de Rochars, VM; Bogus, J; Direny, AN; Dubray, CL; Ernest, JR; Fayette, CR; Goss, CW; Hast, M; Lemoine, JF; O'Brian, K; Pavilus, GE; Sabin, DF; Sircar, AD; Weil, GJ; Wiegand, RE | 1 |
| Adelamo, S; Danyobi, J; Eigege, A; Griswold, E; Kadimbo, J; Michael, E; Miri, E; Nwodu, K; Richards, FO; Sambo, Y; Singh, BK; Smith, ME; Umaru, J | 1 |
| Al-Kubati, AS; Al-Kubati, S; Al-Samie, AR; Ramzy, RMR | 1 |
| Fischer, PU; Goss, CW; Koudou, BG; Lew, D; Loukouri, A; Méité, A; N'Goran, EK; Weil, GJ | 1 |
| Das, PK; Hoti, SL; Jambulingam, P; Pani, SP; Sankari, T; Subramanian, S | 1 |
| Gass, K; Graves, PM; Kearns, T; Lau, CL; Mayfield, HJ; Naseri, T; Sheridan, S; Thomsen, R; Willis, GA | 1 |
| Day, TA; Kimber, MJ; Loghry, HJ; Wheeler, NJ; Yuan, W; Zamanian, M | 1 |
| Horton, J; Ottesen, EA | 1 |
| Jacobson, JA; King, JD; Weil, GJ | 1 |
| Bah, MS; Bah, YM; Conteh, A; Hodges, MH; Koroma, JB; Paye, J; Redwood-Sawyerr, V; Sonnie, M; Veinoglou, A; Zhang, Y | 1 |
| Kibe, LW; Kimani, BW; Njomo, DW; Okoyo, C; Omondi, WP; Sultani, HM | 1 |
| Dwivedi, GP; Jambulingam, P; Krishnamoorthy, K; Kuttiatt, VS; Rahi, M; Raju, HKK; Somani, RK; Srividya, A; Subramanian, S; Suryaprakash, MK; Weil, GJ | 1 |
| Basker, N; Beau de Rochars, M; Bogus, J; Dilliott, D; Direny, AN; Dubray, C; Fischer, PU; Ga, AL; Goss, CW; Hardy, M; Howard, C; Jambulingam, P; King, CL; Krentel, A; Laman, M; Lemoine, JF; Mallya, S; Robinson, LJ; Samuela, J; Schechtman, KB; Steer, AC; Supali, T; Tavul, L; Weil, GJ | 1 |
| Amazigo, UV; Boatin, B; Crump, A; Diop Ly, M; Isiyaku, S; Leak, SGA; Okeibunor, JC; Okoronkwo, C; Zoure, HGM | 1 |
| Aboulaye, M; Andersen, B; Bjerum, CM; Goss, CW; King, CL; Kouadio, O; Koudou, BG; Lew, D; Marius, VK; Ouattara, AF; Weil, GJ | 1 |
| Alfian, R; Bogus, J; Christian, M; Destani, Y; Djuardi, Y; Fischer, PU; Iskandar, E; Lew, D; Lomiga, A; Maylasari, R; Minggu, D; Supali, T; Weil, GJ | 1 |
| Alomatu, B; Asiedu, O; Biritwum, NK; Bockarie, MJ; de Souza, DK; Gyapong, JO; Hervie, TE; Koroma, JB; Marfo, B; Mensah, EO; Molyneux, D; Odoom, S; Yeboah, A; Yikpotey, P | 1 |
| Boussinesq, M; Chesnais, CB; Fischer, PU; Missamou, F; Pion, SDS; Weil, GJ | 1 |
| Derua, YA; Jones, C; Malecela, MN; Ngasalla, B; Tarimo, D | 1 |
| Akame, J; Biholong, BD; Bopda, J; Domche, A; Epée, E; Kabore, A; Kamgno, J; Mbickmen-Tchana, S; Nana-Djeunga, HC; Njiokou, F; Njitchouang, GR; Nwane, P; Tarini, A; Tchatchueng-Mbougua, JB; Tchouakui, M; Tougoue, JJ; Zhang, Y | 1 |
| Albonico, M; Ali, S; Ame, SM; Barda, B; Buonfrate, D; Keiser, J; Speich, B | 1 |
| Adelamo, SE; Davies, E; Eigege, A; Evans, DS; Griswold, EP; King, JD; Mancha, B; Miri, ES; Noland, GS; Okoeguale, B; Richards, FO; Umaru, J | 1 |
| Adimazoya, M; Ahorlu, CS; Boakye, DA; de Souza, DK; Frempong, K; Otchere, J; Owusu, IO; Wilson, MD | 1 |
| Aboagye-Antwi, F; Ahorlu, CS; Biritwum, NK; Boakye, DA; de Souza, DK; Kanamitie, JN; Kwansa-Bentum, B; Otchere, J; Wilson, MD | 1 |
| Adu-Amankwah, S; Ahorlu, CS; Biritwum, NK; Boakye, DA; de Souza, DK; Larbi, IA; Mensah, GE; Mensah, SK; Otchere, J | 1 |
| Bakalar, MH; Boussinesq, M; Chesnais, CB; D'Ambrosio, MV; Fletcher, DA; Gounoue-Kamkumo, R; Kamgno, J; Klion, AD; Mackenzie, CD; Nana-Djeunga, HC; Njitchouang, GR; Nutman, TB; Nwane, P; Pion, SD; Stolk, WA; Tchatchueng-Mbouga, JB; Wanji, S | 1 |
| Colatrella, BD; Gustavsen, KM; McCoy, T | 1 |
| Auma, AM; Byamukama, E; Gabriel, M; Habomugisha, P; Katabarwa, M; Luroni, LT; Nyaraga, M; Oguttu, D; Onapa, AW; Tinkitina, B; Tukahebwa, E; Tukesiga, E; Unnasch, TR | 1 |
| Aparicio, P; Benito, A; Canorea, I; Cenzual, G; Crainey, JL; Lanza, M; Miguel-Oteo, M; Moya, L; Nguema, J; Rubio, JM; Ta, TH | 1 |
| Basáñez, MG; Cano, J; O'Hanlon, SJ; Pullan, RL; Rebollo, MP; Tekle, AH; Wanji, S; Zouré, HG | 1 |
| Boussinesq, M; Chesnais, CB; Kamgno, J; Klion, AD; Mackenzie, CD; Nana-Djeunga, HC; Nutman, TB; Pion, SD | 1 |
| Harischandra, H; Kimber, MJ; Loghry, HJ; Yuan, W; Zamanian, M | 1 |
| Andersen, BJ; Budge, PJ; Herbert, C; Weil, GJ | 1 |
| Brown, P; de Vlas, SJ; de Vos, AS; Hollingsworth, TD; Irvine, MA; Kloek, M; Kontoroupis, P; Michael, E; Prada, JM; Smith, ME; Stolk, WA; Subramanian, S; Touloupou, P | 1 |
| Bah, M; Conteh, A; Hodges, MH; Koroma, JB; Paye, J; Sesay, S; Sonnie, M; Zhang, Y | 1 |
| Adelamo, S; Anagbogu, I; Eigege, A; Emukah, E; Griswold, E; Ikogho, C; Ityonzughul, C; Kadiri, S; Miri, ES; Richards, FO; Saka, YA; Ugbadamu, P | 1 |
| Goodhew, B; Kasubi, M; Lammie, P; Martin, D; Mkocha, H; Wiegand, R | 1 |
| Bockarie, M; Chounna Ndongmo, WP; Enyong, PA; Fobi, G; Fombad, FF; Kengne-Ouafo, JA; Koudou, B; Longang Tchounkeu, YF; Njouendou, AJ; Roungou, JB; Wanji, S | 1 |
| Lorenz, WW; McCoy, CJ; Rada, B; Reaves, BJ; Wallis, C; Wolstenholme, AJ | 1 |
| Aba, E; Brika, P; Fischer, PU; King, CL; Kouakou, MM; Kouakou, R; Koudou, BG; Meite, A; Ouattara, AF; Weil, GJ; Yeo, S | 1 |
| Cheng, YC; Goss, CW; Kazura, JW; King, CL; Mancuso, B; Robinson, LJ; Sanuku, N; Satofan, S; Siba, PM; Suamani, J; Weil, GJ | 1 |
| Bockarie, M; Derua, YA; Jones, C; Malecela, MN; Ngasala, B; Reimer, L; Tarimo, D | 1 |
| Biritwum, NK; Idun, B; Mechan, F; Minetti, C; Osei-Atweneboana, MY; Prada, JM; Reimer, LJ; Tettevi, EJ | 1 |
| Budhathoki, SS; Garner, P; Johnson, S; Macfarlane, CL; Richardson, M | 1 |
| Geary, TG; Mackenzie, CD; Silber, SA | 1 |
| Angkanasinsiri, A; Loymek, S; Priyavoravong, P; Sarasombath, PT; Thammapalo, S; Wongkamchai, S | 1 |
| Bjerum, CM; Chhonker, YS; Edi, C; King, CL; Koudou, BG; Méité, A; Murry, DJ; Ouattara, AF; Penali, LK; Weil, GJ | 1 |
| Debrah, AY; Debrah, LB; Hoerauf, A; Kwarteng, A; Layland, LE; Mubarik, Y; Osei-Mensah, J; Pfarr, K; Ritter, M | 1 |
| Adjinacou-Badou, EG; Batcho, W; Boko-Collins, PM; Cohn, DA; Dare, A; Dossa, NI; Gbaguidi-Saizonou, L; Ibikounle, M; Ogouyemi-Hounto, A; Zoerhoff, KL | 1 |
| Dubray, C; Fischer, PU; Goss, CW; Hardy, M; Jambulingam, P; King, CL; Laman, M; Lemoine, JF; O'Brian, K; Robinson, LJ; Samuela, J; Schechtman, KB; Subramanian, S; Supali, T; Weil, GJ | 1 |
| Jambulingam, P; Krishnamoorthy, K; Nandha, B | 1 |
| Coulibaly, YI; Daou, A; Dicko, I; Doumbia, M; Haidara, FC; Horton, J; Keita, M; Keita, MM; Sankare, MH; Sow, SO; Whately-Smith, C | 1 |
| Kuehn, BM | 1 |
| Hoerauf, A; Slatko, BE; Taylor, MJ; Townson, S; Ward, SA | 1 |
| Derua, YA; Kisinza, WN; Magesa, SM; Malecela, MN; Pedersen, EM; Simonsen, PE | 1 |
| Bockarie, MJ; Rebollo, MP | 1 |
| Emukah, E; Graves, PM; Miri, ES; Mosher, A; Njoku, C; Nkwocha, O; Nwankwo, L; Nwodu, K; Nwoke, BE; Obasi, A; Ozaki, M; Patterson, A; Rakers, L; Richards, FO; Ukaga, CN | 1 |
| Adelamo, SE; Chuwang, YS; Danboyi, J; Danjuma, G; Eigege, A; Kal, A; Mafuyai, H; Mancha, BS; Miri, E; Okoeguale, B; Patterson, AE; Rakers, L; Richards, FO; Sallau, A; Umaru, J | 1 |
| Addiss, DG; Beau de Rochars, VM; Blackstock, AJ; Eddy, BA; Fox, LM; Streit, TG; Williamson, JM | 1 |
| Bougma, RW; Kelly-Hope, LA; Koudou, BG; Kyelem, D; Molyneux, DH; Stanton, MC | 1 |
| Chungpivat, S; Taweethavonsawat, P | 1 |
| Fleckenstein, L; King, CL; Sanuku, N; Schmidt, MS; Siba, PM; Thomsen, EK | 1 |
| Adamani, W; Alphonsus, K; Eigege, A; Evans, DS; Gonzales-Peralta, C; Mafuyai, H; Miri, E; Okoeguale, B; Pede, E; Richards, FO; Saka, Y; Umaru, J; Umbugadu, C | 1 |
| Kisoka, WJ; Malecela, MN; Meyrowitsch, DW; Mushi, DL; Simonsen, PE; Tersbøl, BP | 1 |
| Bronzan, RN; Dorkenoo, AM; Mathieu, E; Ouro-Medeli, A; Seim, A; Sodahlon, YK; Sossou, E; Teko, M; Yakpa, K | 1 |
| Ang, KH; Arkin, M; Bell, A; Bidlow, CM; Bulman, CA; Chen, S; Cho-Ngwa, F; Debnath, A; Franklin, C; Gut, J; Knudsen, GM; Lim, KC; Lustigman, S; Marcellino, C; McKerrow, JH; Rascón, AA; Sakanari, JA; Samje, M; Supakorndej, N; Supakorndej, P; Suzuki, B; Tricoche, N; Williams, D; Wilson, C; Wolfe, AR | 1 |
| Bockarie, MJ; Coulibaly, ME; Coulibaly, SY; Coulibaly, YI; Dembele, B; Diallo, AA; Dolo, H; Doumbia, SS; Klion, AD; Konaté, S; Molyneux, D; Nutman, TB; Soumaoro, L; Toure, YT; Traore, SF | 1 |
| Evans, DS; Richards, FO; Unnasch, TR | 1 |
| Baea, M; Fleckenstein, LL; Kazura, JW; King, CL; Lombore, B; Maki, E; Sanuku, N; Satofan, S; Schmidt, MS; Siba, PM; Thomsen, EK; Weil, GJ | 1 |
| Aboagye-Antwi, F; Ahorlu, CK; Appawu, MA; Boakye, DA; Dadzie, SK; Gyapong, J; Kwansa-Bentum, B; Wilson, MD | 1 |
| Akosa, A; Budge, PJ; Deming, M; Mathieu, EM; Sognikin, E | 1 |
| Endeshaw, T; Katabarwa, MN; Richards, FO; Seid, T; Shafi, O; Tadesse, Z; Taye, A | 1 |
| Clowes, P; Haule, A; Hoelscher, M; Hoerauf, A; Kowuor, D; Kroidl, I; Löscher, T; Maboko, L; Mabuye, J; Maganga, L; Makunde, WH; Malecela, MN; Mgeni, N; Mviombo, P; Mwingira, U; Pitter, B; Saathof, E | 1 |
| Katoch, D; Kumar, N; Kushwaha, V; Lal, B; Murthy, PK; Saxena, K; Singh, B; Verma, R; Verma, SK | 1 |
| de Vlas, SJ; Jambulingam, P; Stolk, WA; Subramanian, S; Vinubala, C | 1 |
| Drabo, F; Kafando, CM; Koala, L; Nikiema, A; Paré, AB; Post, RJ; Traoré, S | 1 |
| Badara Ly, A; Cama, VA; Cantey, PT; Cohn, D; Diawara, L; Direny, A; Dubray, C; Fall, M; Feeser, KR; Fox, LM; Kabore, A; Ndiaye, D; Seck, AF; Sy, N; Wilson, NO | 1 |
| King, J; Mikhailov, A; Montresor, A; Mupfasoni, D | 1 |
| Hollingsworth, TD; Irvine, MA; Michael, E; Singh, BK; Smith, ME; Stolk, WA; Subramanian, S; Weil, GJ | 1 |
| Fischer, PU; Jacobson, JA; King, CL; Weil, GJ | 1 |
| Magnussen, P; Massa, K; Ndawi, B; Ntakamulenga, R; Olsen, A; Sheshe, A | 1 |
| Molyneux, DH | 2 |
| Coulibaly, SY; Coulibaly, YI; Dembele, B; Diallo, AA; Diallo, DA; Doumbia, SS; Doumbo, OK; Fay, MP; Keita, AD; Klion, AD; Konate, S; Kubofcik, J; Lipner, EM; Nutman, TB; Traore, AK; Traore, SF; Yalcouye, D | 1 |
| Hopkins, AD; Molyneux, DH | 1 |
| Bradley, MH; Gustavsen, KM; Wright, AL | 1 |
| Biswas, G; Bradley, MH; Hooper, PJ; Ottesen, EA | 1 |
| Horton, J | 1 |
| Derua, YA; Magesa, SM; Malecela, MN; Pedersen, EM; Rwegoshora, RT; Simonsen, PE | 1 |
| Bockarie, M; Hoerauf, A; Taylor, MJ | 1 |
| Chebil, M; Derouiche, A; El Atat, R; Ezzeddine, A; Garbouj, N; Khaled, A; Mechri, M | 1 |
| Kabatereine, N; Namwanje, H; Olsen, A | 1 |
| Bush, S; Hopkins, AD | 1 |
| Akogun, MK; Akogun, OB; Apake, E; Kale, OO | 1 |
| Das, MK; Laxmanappa, HS; Ramasamy, D; Sharma, R | 1 |
| Geary, TG; Mackenzie, CD | 1 |
| Aborigo, R; Adjuik, M; Akweongo, P; Amankwa, J; Anto, F; Anyorigiya, T; Asoala, V; Bimi, L; Hodgson, A; Oduro, A | 1 |
| Debrah, AY; Hoerauf, A; Mand, S; Pfarr, K; Specht, S | 1 |
| Ashton, RA; Auma, A; Brooker, S; Edwards, T; Kolaczinski, JH; Kyabayinze, DJ; Matwale, G; Onapa, A; Opio, T | 1 |
| Bockarie, MJ; Shenoy, RK | 1 |
| Beach, MJ; Boyd, A; Kucerova, Z; Lammie, PJ; Moss, DM; Priest, JW; Weinkopff, T | 1 |
| Adelamo, SE; Danboyi, J; Eigege, A; Goshit, D; Hopkins, DR; Ibrahim, B; Jiya, J; Kal, A; Mathieu, E; Miri, ES; Ogah, G; Oyenekan, OK; Pam, D; Rakers, LJ; Richards, FO; Saka, YA; Sambo, Y; Umaru, J; Withers, PC | 1 |
| Gupta, J; Misra, S; Misra-Bhattacharya, S; Sashidhara, KV; Singh, SP | 1 |
| Alphonsus, KM; Eigege, A; Graves, P; Jip, N; Jiya, J; King, JD; Miri, E; Richards, F; Sambo, Y; Umaru, J | 1 |
| Conteh, A; Hodges, MH; Maccarthy, F; Sesay, S; Sonnie, M; Turay, H | 1 |
| Deb, RM; Mohammed, KA; Molyneux, DH; Stanton, MC | 1 |
| Das, PK; Pani, SP; Ramaiah, KD; Vanamail, P; Yuvaraj, J | 2 |
| Alexander, ND; Alpers, MP; Bockarie, F; Bockarie, MJ; Dimber, Z; Ibam, E; Kastens, W; Kazura, JW; Tisch, DJ | 1 |
| Ottesen, EA | 1 |
| Krishnamoorthy, K; Rajendran, R; Reuben, R; Sunish, IP | 1 |
| Curtis, CF; Malecela-Lazaro, M; Maxwell, CA; Reuben, R | 1 |
| Das, PK; Subramanian, S | 1 |
| Molyneux, DH; Zagaria, N | 1 |
| Adjei, O; Büttner, DW; Debrah, AY; Fischer, K; Hoerauf, A; Kruppa, T; Mand, S; Marfo-Debrekyei, Y; Pfarr, KM | 1 |
| Bradley, M; Hoerauf, A; Kyelem, D; Molyneux, DH; Taylor, MJ | 1 |
| Das, PK; Habbema, JD; Stolk, WA; Swaminathan, S; van Oortmarssen, GJ | 1 |
| Das, PK; Pani, SP; Ramaiah, KD; Vanamail, P | 2 |
| Chinbuah, MA; Gyapong, JO; Gyapong, M | 1 |
| Addiss, D; Critchley, J; Ejere, H; Gamble, C; Garner, P; Gelband, H | 3 |
| Melrose, WD | 1 |
| Crump, A; Omura, S | 1 |
| Amadiegwu, S; Dakul, A; Danboyi, J; Eigege, A; Gerlong, GY; Ibrahim, B; Jinadu, MY; Kal, A; Kumbak, D; Lenhart, A; Mafuyai, H; Miri, ES; Onyeka, J; Pam, DD; Rakers, L; Richards, FO; Sambo, Y; Terranella, A; Umaru, J; Withers, PC | 1 |
| Das, PK; Pani, SP; Ramaiah, KD; Subramanian, S; Vanamail, P; Yuvaraj, J | 1 |
| McCarthy, J | 1 |
| Boatin, B; Bonkoungou, M; Kyelem, D; Medlock, J; Molyneux, DH; Sanou, S | 1 |
| DAS, PK; DE Vlas, SJ; Habbema, JD; Pani, SP; Stolk, WA; Subramanian, S; VAN Oortmarssen, GJ | 1 |
| Molyneux, DH; Nantulya, V | 1 |
| Das, LK; Pani, SP; Reddy, GS; Vanamail, P; Venkatesvarlou, N; Vijayan, AP | 1 |
| de Kraker, ME; Habbema, JD; Stolk, WA; van Oortmarssen, GJ | 1 |
| Dash, AP; Mani, TR; Munirathinam, A; Rajendran, R; Reuben, R; Sunish, IP | 1 |
| Coulibaly, YI; Diallo, AA; Diallo, DA; Doumbo, OK; Keiser, PB; Keita, F; Klion, AD; Kubofcik, J; Nutman, TB; Semnani, RT; Traore, D; Traore, SF | 1 |
| Blackburn, BG; Eigege, A; Gerlong, G; Gotau, H; Hawley, WA; Mathieu, E; Miri, E; Richards, F | 1 |
| Dilu, NJ; Sokolo, R | 1 |
| Dash, AP; Mani, TR; Munirathinam, A; Rajendran, R; Sunish, IP; Tyagi, BK | 1 |
| DAS, PK; Vanamail, P | 1 |
| Carron, J; Durrheim, DN; Gyapong, M; Melrose, WD; Wynd, S | 1 |
| Adjei, O; Batsa, L; Buttner, D; Buttner, M; Debrah, AY; Hoerauf, A; Mand, S; Marfo-Debrekyei, Y; Pfarr, K | 1 |
| Biswas, G; Bradley, MH; Chitsulo, L; Engels, D; Gabrielli, AF; Haji, HJ; Mohammed, KA; Molyneux, DH; Mubila, L; Savioli, L | 1 |
| Alpers, MP; Bockarie, MJ; Dimber, Z; Hazlett, FE; Kastens, W; Kazura, JW; Kiniboro, B; Tarongka, N; Tisch, DJ | 1 |
| Eigege, A; Jinadu, MY; Miri, E; Njepuome, AN; Ogbu Pearce, P; Pede, E; Umaru, J | 1 |
| Kar, SK; Kumaraswami, V; Murty, RS; Patnaik, S | 1 |
| Navaratnam, V | 1 |
| Cardines, R; Cartel, JL; Chanteau, S; Glaziou, P; Martin, PM; Moulia-Pelat, JP; Nguyen, LN; Ottesen, EA | 1 |
| Cartel, JL; Chanteau, S; Glaziou, P; Martin, PM; Moulia-Pelat, JP; Nguyen, LN | 1 |
| Andrade, LD; Coutinho, AD; Dreyer, G; Galdino, E; Lopes, E; Machado, G; Medeiros, Z; Moura, I; Rizzo, JA; Rocha, A | 1 |
| Alpers, M; Day, K; Greenberg, J; Kazura, J; Perry, R; Weil, G | 1 |
| Kumaraswami, V; Rajan, K; Shenoy, RK; Thankom, S | 1 |
| Kar, SK; Kumaraswami, V; Mania, J; Patnaik, S | 1 |
| Kazura, JW | 1 |
| Cartel, JL; Chanteau, S; Gay, VM; Glaziou, P; Martin, PM; Moulia-Pelat, JP; Nguyen, LN | 1 |
| Chen, XR; Cheng, SZ; Cheng, WF; Gan, GB; Luo, LF; Piessens, WF; Tao, ZH; Wang, SH; Ye, YM; Zheng, HJ | 2 |
| Addiss, DG; Eberhard, ML; Lammie, PJ; Lee, SH; McNeeley, DF; McNeeley, MB; Spencer, HC | 1 |
| Cartel, JL; Glaziou, P; Moulia-Pelat, JP; Nguyen, LN | 1 |
| Hascoet, H; Moulia-Pelat, JP; Nguyen, LN; Nicolas, L | 1 |
| Addiss, D; Amaral, F; Coutinho, A; Dreyer, G; Noroes, J; Rocha, A | 1 |
| Cao, WC; Habbema, JD; Plaisier, AP; Van der Ploeg, CP; van der Sluijs, IJ | 1 |
| Alexander, ND; Alpers, MP; Bockarie, F; Bockarie, MJ; Dimber, Z; Hyun, P; Ibam, E; Kazura, JW | 1 |
| Behbehani, K; Duke, BO; Karam, M; Ottesen, EA | 1 |
| Kumaraswami, V; Rajan, K; Shenoy, RK; Suma, TK | 1 |
| Deparis, X; Langy, S; Nicolas, L; Plichart, C | 1 |
| Horton, J; Ismail, MM; Ottesen, EA | 1 |
| Addiss, DG; Beach, MJ; Lammie, PJ; Prospere, R; Roberts, JM; Streit, TG | 1 |
| Alexander, ND; Alpers, MP; Bockarie, F; Bockarie, MJ; Dagoro, H; Hii, JL; Kazura, JW | 1 |
| Dean, M | 1 |
| Dalia, S; John, A; Kumaraswami, V; Shenoy, RK; Suma, TK | 1 |
| Cox, FE | 1 |
| Habbema, JD; Plaisier, AP; Stolk, WA; van Oortmarssen, GJ | 1 |
| Dreyer, G; Figueredo-Silva, J; Norões, J; Piessens, WF | 1 |
| Gyapong, JO; Gyapong, M; Owusu-Banahene, G | 1 |
| Karam, M; Ottesen, E | 1 |
| Brown, KR; Ottesen, EA; Ricci, FM | 1 |
| Addiss, DG; Awadzi, K; Beach, MJ; Belizario, VY; Dunyo, SK; Espinel, M; Gyapong, JO; Horton, J; Hossain, M; Ismail, MM; Jayakody, RL; Lammie, PJ; Lazdins, JK; Makunde, W; Ottesen, EA; Richard-Lenoble, D; Selve, B; Shenoy, RK; Simonsen, PE; Wamae, CN; Weerasooriya, MV; Witt, C | 1 |
| Bergmann, F; Göbels, K; Grobusch, MP; Suttorp, N; Teichmann, D | 1 |
| Klei, TR; Rao, UR; Williams, SA | 1 |
| Cartel, JL; Chanteau, S; Glaziou, P; Moulia-Pelat, JP; Nguyen, LN; Roux, JF | 1 |
| Cartel, JL; Martin, PM; Moulia-Pelat, JP; Nguyen, LN; Roux, JF; Spiegel, A | 1 |
| Cardines, R; Cartel, JL; Martin, PM; Moulia-Pelat, JP; Nguyen Ngnoc, L; Plichart, R; Roux, JF; Spiegel, A | 1 |
| Eberhard, ML; Lammie, PJ; Roberts, JM; Wamae, CN | 1 |
| Cardines, R; Cartel, JL; Martin, PM; Nguyen Ngnoc, L; Plichart, R; Roux, JF; Spiegel, A | 1 |
| Barbazan, P; Cartel, JL; Martin, PM; Nguyen, L; Roux, JF; Sechan, Y; Spiegel, A | 1 |
| Chen, XR; Cheng, SH; Cheng, WF; Gan, GB; Luo, LF; Piessens, WF; Tao, ZH; Wang, SH; Ye, YM; Zheng, HJ | 2 |
| Mak, JW; Navaratnam, V; Ramachandran, CP | 1 |
| Eberhard, ML; Lammie, PJ; Richards, FO; Weil, GJ | 1 |
| Cartel, JL; Martin, PM; Nguyen, L; Plichart, R; Roux, JF; Spiegel, A | 1 |
| Bernard, Y; Bryan, RT; Eberhard, ML; Hightower, AW; Lammie, PJ; McNeeley, DF; McNeeley, MB; Richards, FO; Spencer, HC | 1 |
| Cartel, JL; Genelle, B; Nguyen, L; Roux, JF; Spiegel, A | 1 |
| Frederick, S; Kumaraswami, V; Ottesen, EA; Perumal Pillai, SV; Prabhakar, R; Sadanandam, A; Tripathy, SP; Vijayasekaran, V | 1 |
| Liu, LX; Weller, PF | 1 |
| Kwa, BH; Nayar, JK; Rao, UR; Vickery, AC | 1 |
| Boutin, JP; Cartel, JL; Celerier, P; Plichart, R; Roux, JF; Sechan, Y | 1 |
| Chandrashekar, R; Rao, UR; Subrahmanyam, D | 1 |
| Aziz, MA; Boutin, JP; Cartel, JL; Larivière, M; Perolat, P; Roux, J; Sechan, Y | 1 |
| Aziz, MA; Badiane, S; Bah, IB; Diallo, S; Gaye, O; Ndir, O | 1 |
| Dissanaike, AS | 1 |
| Aziz, MA; Devi, U; Kumaraswami, V; Ottesen, EA; Prabhakar, R; Sarma, GR; Swaminathan, M; Tripathy, SP; Vijayasekaran, V | 1 |
| Lam, PL; Mak, JW; Rain, AN; Suresh, K | 2 |
36 review(s) available for dextrothyroxine and Elephantiasis, Filarial
| Article | Year |
|---|---|
Efficacy and safety of triple therapy versus dual therapy for lymphatic filariasis: A systematic review and meta-analysis.
Topics: Albendazole; Animals; Diethylcarbamazine; Drug Therapy, Combination; Elephantiasis, Filarial; Filaricides; Humans; Ivermectin; Microfilariae | 2022 |
Pharmacokinetics, feasibility and safety of co-administering azithromycin, albendazole, and ivermectin during mass drug administration: A review.
Topics: Albendazole; Azithromycin; Drug Therapy, Combination; Elephantiasis, Filarial; Feasibility Studies; Humans; Ivermectin; Mass Drug Administration; Neglected Diseases | 2023 |
The story of Lymphatic Filariasis elimination as a public health problem from Yemen.
Topics: Albendazole; Animals; Elephantiasis, Filarial; Humans; Ivermectin; Mass Drug Administration; Public Health; Yemen | 2020 |
Setting the stage for a Global Programme to Eliminate Lymphatic Filariasis: the first 125 years (1875-2000).
Topics: Albendazole; Diethylcarbamazine; Elephantiasis, Filarial; Filaricides; Humans; Ivermectin | 2020 |
Community-directed distributors-The "foot soldiers" in the fight to control and eliminate neglected tropical diseases.
Topics: Africa South of the Sahara; Community Health Services; Community Health Workers; Elephantiasis, Filarial; Female; Humans; Ivermectin; Mass Drug Administration; Neglected Diseases; Onchocerciasis | 2021 |
Fifteen years of programme implementation for the elimination of Lymphatic Filariasis in Ghana: Impact of MDA on immunoparasitological indicators.
Topics: Albendazole; Animals; Anthelmintics; Elephantiasis, Filarial; Endemic Diseases; Ghana; Humans; Ivermectin; Mass Drug Administration; National Health Programs; Prevalence | 2017 |
Adverse events following single dose treatment of lymphatic filariasis: Observations from a review of the literature.
Topics: Albendazole; Diethylcarbamazine; Drug Therapy, Combination; Elephantiasis, Filarial; Filaricides; Humans; Ivermectin | 2018 |
Albendazole alone or in combination with microfilaricidal drugs for lymphatic filariasis.
Topics: Albendazole; Antigens, Helminth; Diethylcarbamazine; Drug Therapy, Combination; Elephantiasis, Filarial; Filaricides; Humans; Ivermectin; Randomized Controlled Trials as Topic | 2019 |
Flubendazole as a macrofilaricide: History and background.
Topics: Albendazole; Animals; Diethylcarbamazine; Elephantiasis, Filarial; Filaricides; Gastrointestinal Diseases; Humans; Ivermectin; Mebendazole; Microfilariae; Onchocerca volvulus; Onchocerciasis; Wuchereria bancrofti | 2019 |
Anti-Wolbachia drug discovery and development: safe macrofilaricides for onchocerciasis and lymphatic filariasis.
Topics: Animals; Anti-Bacterial Agents; Brugia malayi; Child; Doxycycline; Drug Discovery; Elephantiasis, Filarial; Female; Filaricides; Humans; Ivermectin; Loiasis; Onchocerca volvulus; Onchocerciasis; Pregnancy; Symbiosis; Wolbachia | 2014 |
Toward the elimination of lymphatic filariasis by 2020: treatment update and impact assessment for the endgame.
Topics: Albendazole; Anthelmintics; Chemoprevention; Diethylcarbamazine; Disease Eradication; Elephantiasis, Filarial; Epidemiological Monitoring; Humans; Ivermectin; Models, Theoretical | 2013 |
The development of albendazole for lymphatic filariasis.
Topics: Albendazole; Animals; Drug Administration Schedule; Drug Therapy, Combination; Elephantiasis, Filarial; Filaricides; Humans; Ivermectin; Public Health | 2009 |
Lymphatic filariasis and onchocerciasis.
Topics: Africa South of the Sahara; Age Factors; Albendazole; Animals; Anti-Bacterial Agents; Antinematodal Agents; Blindness; Culicidae; Dermatitis; Dermatologic Agents; Diethylcarbamazine; Doxycycline; Drug Therapy, Combination; Elephantiasis, Filarial; Filaricides; Gram-Negative Bacterial Infections; Granuloma; Humans; India; Ivermectin; Lymphadenitis; Lymphangitis; Lymphedema; Macrolides; Onchocerciasis; Prevalence; Symbiosis; Wolbachia | 2010 |
Filariasis in Africa--treatment challenges and prospects.
Topics: Africa; Albendazole; Animals; Elephantiasis, Filarial; Filaricides; Humans; Ivermectin; Onchocerca volvulus; Onchocerciasis; Symbiosis; Wolbachia; Wuchereria bancrofti | 2011 |
Lymphatic filariasis in children: clinical features, infection burdens and future prospects for elimination.
Topics: Albendazole; Animals; Anthelmintics; Brugia; Child; Elephantiasis, Filarial; Female; Humans; Ivermectin; Male; Soil; Wuchereria bancrofti | 2011 |
Lymphatic filariasis elimination: progress in global programme development.
Topics: Albendazole; Developing Countries; Disability Evaluation; Elephantiasis, Filarial; Filaricides; Financing, Organized; Health Services; Humans; International Cooperation; Ivermectin; Organizations; Program Development; World Health Organization | 2002 |
Mass drug treatment for lymphatic filariasis and onchocerciasis.
Topics: Africa; Albendazole; Animals; Drug Evaluation, Preclinical; Drug Resistance; Elephantiasis, Filarial; Endemic Diseases; Filaricides; Humans; Ivermectin; Onchocerciasis | 2003 |
Albendazole for lymphatic filariasis.
Topics: Albendazole; Diethylcarbamazine; Elephantiasis, Filarial; Filaricides; Humans; Ivermectin; Randomized Controlled Trials as Topic | 2004 |
Chemotherapy for lymphatic filariasis: progress but not perfection.
Topics: Albendazole; Animals; Diethylcarbamazine; Drug Therapy, Combination; Elephantiasis, Filarial; Humans; Ivermectin; Wuchereria bancrofti | 2003 |
The life and times of ivermectin - a success story.
Topics: Africa; Americas; Animals; Anthelmintics; Community Networks; Costs and Cost Analysis; Elephantiasis, Filarial; Humans; Ivermectin; Life Cycle Stages; Onchocerca volvulus; Onchocerciasis; Streptomyces | 2004 |
Albendazole for the control and elimination of lymphatic filariasis: systematic review.
Topics: Adult; Albendazole; Diethylcarbamazine; Drug Therapy, Combination; Elephantiasis, Filarial; Filaricides; Humans; Ivermectin; Randomized Controlled Trials as Topic; Treatment Outcome | 2005 |
Albendazole for lymphatic filariasis.
Topics: Albendazole; Diethylcarbamazine; Drug Therapy, Combination; Elephantiasis, Filarial; Filaricides; Humans; Ivermectin; Randomized Controlled Trials as Topic | 2005 |
Public-private partnerships in blindness prevention: reaching beyond the eye.
Topics: Blindness; Child; Drug Industry; Elephantiasis, Filarial; Humans; Ivermectin; Loiasis; Malaria; Onchocerciasis, Ocular | 2005 |
Model-based analysis of trial data: microfilaria and worm-productivity loss after diethylcarbamazine-albendazole or ivermectin-albendazole combination therapy against Wuchereria bancrofti.
Topics: Adolescent; Adult; Aged; Albendazole; Animals; Anthelmintics; Antiparasitic Agents; Child; Diethylcarbamazine; Drug Therapy, Combination; Elephantiasis, Filarial; Filaricides; Humans; Ivermectin; Longevity; Microfilariae; Middle Aged; Models, Statistical; Randomized Controlled Trials as Topic; Research Design; Treatment Outcome; Wuchereria bancrofti | 2006 |
Understanding the community impact of lymphatic filariasis: a review of the sociocultural literature.
Topics: Albendazole; Community Health Services; Cultural Characteristics; Diethylcarbamazine; Drug Therapy, Combination; Elephantiasis, Filarial; Filaricides; Health Knowledge, Attitudes, Practice; Humans; Ivermectin; Life Style; Prejudice | 2007 |
Recent advances in the chemotherapy of lymphatic filariasis.
Topics: Benzimidazoles; Benzothiazoles; Diethylcarbamazine; Elephantiasis, Filarial; Filaricides; Humans; Ivermectin; Thiabendazole; Thiazoles | 1993 |
Ivermectin and human lymphatic filariasis.
Topics: Animals; Caenorhabditis elegans; Elephantiasis, Filarial; Humans; Ivermectin; Molecular Structure | 1993 |
Ivermectin for the chemotherapy of bancroftian filariasis: a meta-analysis of the effect of single treatment.
Topics: Elephantiasis, Filarial; Filaricides; Humans; Ivermectin | 1997 |
Strategies and tools for the control/elimination of lymphatic filariasis.
Topics: Adult; Africa; Albendazole; Animals; Anthelmintics; Asia; Child; Diethylcarbamazine; Drug Administration Schedule; Elephantiasis, Filarial; Female; Filaricides; Humans; Ivermectin; Male; Microfilariae; Superinfection | 1997 |
The role of albendazole in programmes to eliminate lymphatic filariasis.
Topics: Albendazole; Animals; Brugia malayi; Diethylcarbamazine; Elephantiasis, Filarial; Filaricides; Humans; Ivermectin; Male; Microfilariae; Patient Compliance; Public Health; Wuchereria bancrofti | 1999 |
Effectiveness of annual ivermectin treatment for Wuchereria bancrofti infection.
Topics: Animals; Elephantiasis, Filarial; Filaricides; Humans; Ivermectin; Models, Biological; Treatment Outcome; Wuchereria bancrofti | 2000 |
Pathogenesis of lymphatic disease in bancroftian filariasis: a clinical perspective.
Topics: Albendazole; Animals; Anthelmintics; Diethylcarbamazine; Elephantiasis, Filarial; Female; Filaricides; Humans; Ivermectin; Lymphangitis; Male; Models, Biological; Scrotum; Testicular Hydrocele; Wuchereria bancrofti | 2000 |
[The control of lymphatic filariasis].
Topics: Albendazole; Animals; Anthelmintics; Brugia; Brugia malayi; Disease Vectors; Elephantiasis, Filarial; Humans; Ivermectin; Wuchereria bancrofti | 2000 |
Ivermectin: effectiveness in lymphatic filariasis.
Topics: Anthelmintics; Clinical Trials as Topic; Elephantiasis, Filarial; Humans; Ivermectin | 2000 |
An analysis of the safety of the single dose, two drug regimens used in programmes to eliminate lymphatic filariasis.
Topics: Albendazole; Clinical Trials as Topic; Diethylcarbamazine; Drug Synergism; Drug Therapy, Combination; Elephantiasis, Filarial; Filaricides; Humans; Ivermectin; National Health Programs; World Health Organization | 2000 |
Experimental chemotherapy of lymphatic filariasis. A review.
Topics: Animals; Cats; Disease Models, Animal; Dogs; Elephantiasis, Filarial; Filaricides; Humans; Ivermectin; Organic Chemicals; Piperazines; Thiazoles | 1991 |
66 trial(s) available for dextrothyroxine and Elephantiasis, Filarial
| Article | Year |
|---|---|
Safety and efficacy of mass drug administration with a single-dose triple-drug regimen of albendazole + diethylcarbamazine + ivermectin for lymphatic filariasis in Papua New Guinea: An open-label, cluster-randomised trial.
Topics: Adolescent; Adult; Aged; Albendazole; Animals; Child; Child, Preschool; Diethylcarbamazine; Drug Therapy, Combination; Elephantiasis, Filarial; Female; Filaricides; Humans; Ivermectin; Male; Mass Drug Administration; Middle Aged; Papua New Guinea; Treatment Outcome; Wuchereria bancrofti; Young Adult | 2022 |
Community-based trial assessing the impact of annual versus semiannual mass drug administration with ivermectin plus albendazole and praziquantel on helminth infections in northwestern Liberia.
Topics: Albendazole; Animals; Cross-Sectional Studies; Elephantiasis, Filarial; Helminthiasis; Humans; Ivermectin; Liberia; Mass Drug Administration; Onchocerciasis; Praziquantel; Prevalence; Soil; Wuchereria bancrofti | 2022 |
Mass drug administration of ivermectin, diethylcarbamazine, plus albendazole compared with diethylcarbamazine plus albendazole for reduction of lymphatic filariasis endemicity in Papua New Guinea: a cluster-randomised trial.
Topics: Albendazole; Cross-Sectional Studies; Diethylcarbamazine; Drug Therapy, Combination; Elephantiasis, Filarial; Female; Filaricides; Humans; Ivermectin; Mass Drug Administration; Papua New Guinea | 2022 |
A randomized, open-label study of the tolerability and efficacy of one or three daily doses of ivermectin plus diethylcarbamazine and albendazole (IDA) versus one dose of ivermectin plus albendazole (IA) for treatment of onchocerciasis.
Topics: Albendazole; Diethylcarbamazine; Drug Therapy, Combination; Elephantiasis, Filarial; Female; Filaricides; Humans; Ivermectin; Onchocerciasis; Pilot Projects | 2023 |
Safety and tolerability of moxidectin and ivermectin combination treatments for lymphatic filariasis in Côte d'Ivoire: A randomized controlled superiority study.
Topics: Adult; Albendazole; Animals; Cote d'Ivoire; Diethylcarbamazine; Drug Therapy, Combination; Elephantiasis, Filarial; Filaricides; Humans; Ivermectin; Wuchereria bancrofti | 2023 |
Systems analysis-based assessment of post-treatment adverse events in lymphatic filariasis.
Topics: Adolescent; Adult; Aged; Albendazole; Antigens, Helminth; Cytokines; Diethylcarbamazine; Elephantiasis, Filarial; Female; Filaricides; Humans; Ivermectin; Male; Middle Aged; Young Adult | 2019 |
Efficacy and Safety of a Single Dose of Ivermectin, Diethylcarbamazine, and Albendazole for Treatment of Lymphatic Filariasis in Côte d'Ivoire: An Open-label Randomized Controlled Trial.
Topics: Albendazole; Animals; Cote d'Ivoire; Diethylcarbamazine; Drug Therapy, Combination; Elephantiasis, Filarial; Filaricides; Ivermectin; Wuchereria bancrofti | 2020 |
The safety of combined triple drug therapy with ivermectin, diethylcarbamazine and albendazole in the neglected tropical diseases co-endemic setting of Fiji: A cluster randomised trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Albendazole; Antiparasitic Agents; Child; Child, Preschool; Community-Acquired Infections; Diethylcarbamazine; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Elephantiasis, Filarial; Female; Fiji; Helminthiasis; Humans; Infant; Insecticides; Ivermectin; Male; Middle Aged; Neglected Diseases; Rural Population; Scabies; Treatment Outcome; Young Adult | 2020 |
Safety and efficacy of co-administered diethylcarbamazine, albendazole and ivermectin during mass drug administration for lymphatic filariasis in Haiti: Results from a two-armed, open-label, cluster-randomized, community study.
Topics: Adolescent; Adult; Albendazole; Animals; Antiparasitic Agents; Child; Child, Preschool; Diethylcarbamazine; Drug Therapy, Combination; Elephantiasis, Filarial; Female; Haiti; Humans; Ivermectin; Logistic Models; Male; Mass Drug Administration; Middle Aged; Prevalence; Treatment Outcome; Young Adult | 2020 |
Heterogeneous response of Wuchereria bancrofti-infected persons to diethylcarbamazine (DEC) and its implications for the Global Programme to Eliminate Lymphatic Filariasis (GPELF).
Topics: Albendazole; Animals; Diethylcarbamazine; Elephantiasis, Filarial; Female; Filaricides; Humans; Ivermectin; Logistic Models; Male; Microfilariae; Wuchereria bancrofti | 2021 |
An open label, block randomized, community study of the safety and efficacy of co-administered ivermectin, diethylcarbamazine plus albendazole vs. diethylcarbamazine plus albendazole for lymphatic filariasis in India.
Topics: Adolescent; Adult; Albendazole; Animals; Child; Diethylcarbamazine; Drug-Related Side Effects and Adverse Reactions; Elephantiasis, Filarial; Female; Filaricides; Humans; India; Ivermectin; Male; Mass Drug Administration; Wuchereria bancrofti | 2021 |
A multicenter, community-based, mixed methods assessment of the acceptability of a triple drug regimen for elimination of lymphatic filariasis.
Topics: Adolescent; Adult; Albendazole; Diethylcarbamazine; Elephantiasis, Filarial; Female; Filaricides; Focus Groups; Humans; Ivermectin; Male; Mass Drug Administration; Middle Aged; Patient Acceptance of Health Care; Professionalism; Surveys and Questionnaires | 2021 |
Semiannual Treatment of Albendazole Alone is Efficacious for Treatment of Lymphatic Filariasis: A Randomized Open-label Trial in Cote d'Ivoire.
Topics: Albendazole; Animals; Cote d'Ivoire; Diethylcarbamazine; Elephantiasis, Filarial; Filaricides; Ivermectin; Wuchereria bancrofti | 2022 |
Individual Efficacy and Community Impact of Ivermectin, Diethylcarbamazine, and Albendazole Mass Drug Administration for Lymphatic Filariasis Control in Fiji: A Cluster Randomized Trial.
Topics: Albendazole; Animals; Australia; Diethylcarbamazine; Drug Therapy, Combination; Elephantiasis, Filarial; Fiji; Filaricides; Humans; Ivermectin; Mass Drug Administration; Wuchereria bancrofti | 2021 |
An open label, randomized clinical trial to compare the tolerability and efficacy of ivermectin plus diethylcarbamazine and albendazole vs. diethylcarbamazine plus albendazole for treatment of brugian filariasis in Indonesia.
Topics: Adolescent; Adult; Aged; Albendazole; Animals; Antibodies, Protozoan; Asymptomatic Diseases; Brugia; Diethylcarbamazine; Drug Therapy, Combination; Elephantiasis, Filarial; Female; Filaricides; Humans; Indonesia; Ivermectin; Male; Microfilariae; Middle Aged; Treatment Outcome; Young Adult | 2021 |
Community-based trial of annual versus biannual single-dose ivermectin plus albendazole against Wuchereria bancrofti infection in human and mosquito populations: study protocol for a cluster randomised controlled trial.
Topics: Albendazole; Animals; Clinical Protocols; Community Health Services; Culicidae; Disease Eradication; Drug Administration Schedule; Drug Therapy, Combination; Elephantiasis, Filarial; Filaricides; Ghana; Humans; Ivermectin; Mass Drug Administration; Prevalence; Research Design; Time Factors; Treatment Outcome; Wuchereria bancrofti | 2017 |
A Trial of a Triple-Drug Treatment for Lymphatic Filariasis.
Topics: Adolescent; Adult; Albendazole; Animals; Diethylcarbamazine; Drug Administration Schedule; Drug Therapy, Combination; Elephantiasis, Filarial; Female; Filaricides; Humans; Ivermectin; Male; Microfilariae; Middle Aged; Parasite Load; Single-Blind Method; Wuchereria bancrofti; Young Adult | 2018 |
Pharmacokinetics, safety, and efficacy of a single co-administered dose of diethylcarbamazine, albendazole and ivermectin in adults with and without Wuchereria bancrofti infection in Côte d'Ivoire.
Topics: Adolescent; Adult; Aged; Albendazole; Animals; Cohort Studies; Cote d'Ivoire; Diethylcarbamazine; Drug Combinations; Elephantiasis, Filarial; Female; Filaricides; Humans; Ivermectin; Male; Middle Aged; Treatment Outcome; Wuchereria bancrofti; Young Adult | 2019 |
Dosing pole recommendations for lymphatic filariasis elimination: A height-weight quantile regression modeling approach.
Topics: Adolescent; Adult; Body Height; Body Weight; Child; Cohort Studies; Diethylcarbamazine; Drug Dosage Calculations; Elephantiasis, Filarial; Female; Filaricides; Global Health; Humans; Ivermectin; Male; Mass Drug Administration; Middle Aged; Models, Statistical; Prevalence; Regression Analysis; Waist-Height Ratio; Young Adult | 2019 |
A cluster randomized study of the safety of integrated treatment of trachoma and lymphatic filariasis in children and adults in Sikasso, Mali.
Topics: Adolescent; Adult; Aged; Albendazole; Anthelmintics; Anti-Bacterial Agents; Azithromycin; Chemoprevention; Child; Child, Preschool; Coinfection; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Elephantiasis, Filarial; Female; Humans; Ivermectin; Male; Mali; Middle Aged; Neglected Diseases; Trachoma; Young Adult | 2013 |
Successful treatment of Brugia pahangi in naturally infected cats with ivermectin.
Topics: Animals; Brugia pahangi; Cat Diseases; Cats; Elephantiasis, Filarial; Filaricides; Ivermectin; Parasite Load; Thailand; Treatment Outcome | 2013 |
Efficacy, Safety, and Pharmacokinetics of Coadministered Diethylcarbamazine, Albendazole, and Ivermectin for Treatment of Bancroftian Filariasis.
Topics: Adult; Albendazole; Animals; Diethylcarbamazine; Drug-Related Side Effects and Adverse Reactions; Elephantiasis, Filarial; Female; Filaricides; Humans; Ivermectin; Male; Middle Aged; Papua New Guinea; Parasitemia; Pilot Projects; Serum; Single-Blind Method; Treatment Outcome; Wuchereria bancrofti; Young Adult | 2016 |
A randomized trial of doxycycline for Mansonella perstans infection.
Topics: Adolescent; Adult; Aged; Albendazole; Animals; Anti-Bacterial Agents; Doxycycline; Drug Therapy, Combination; Elephantiasis, Filarial; Female; Filaricides; Humans; Ivermectin; Male; Mansonella; Mansonelliasis; Middle Aged; Rickettsiaceae Infections; Symbiosis; Treatment Outcome; Wolbachia; Wuchereria bancrofti; Young Adult | 2009 |
A randomised controlled clinical trial on the safety of co-administration of albendazole, ivermectin and praziquantel in infected schoolchildren in Uganda.
Topics: Adolescent; Albendazole; Animals; Antiparasitic Agents; Child; Child, Preschool; Cost-Benefit Analysis; Drug Therapy, Combination; Elephantiasis, Filarial; Female; Helminthiasis; Humans; Ivermectin; Male; Praziquantel; Schistosomiasis; Sentinel Surveillance; Single-Blind Method; Treatment Outcome; Uganda | 2011 |
Multiplex bead assay for serum samples from children in Haiti enrolled in a drug study for the treatment of lymphatic filariasis.
Topics: Anthelmintics; Antibodies, Helminth; Antigens, Helminth; Child; Child, Preschool; Diethylcarbamazine; Elephantiasis, Filarial; Haiti; Humans; Immunoassay; Immunoglobulin G; Ivermectin | 2011 |
The effect of six rounds of single dose mass treatment with diethylcarbamazine or ivermectin on Wuchereria bancrofti infection and its implications for lymphatic filariasis elimination.
Topics: Animals; Community Health Services; Culex; Diethylcarbamazine; Double-Blind Method; Drug Administration Schedule; Elephantiasis, Filarial; Female; Filaricides; Humans; India; Ivermectin; Male; Prevalence; Preventive Health Services; Rural Health; Treatment Outcome; Wuchereria bancrofti | 2002 |
Mass treatment to eliminate filariasis in Papua New Guinea.
Topics: Adolescent; Adult; Animals; Child; Child, Preschool; Culicidae; Diethylcarbamazine; Disease Reservoirs; Drug Administration Schedule; Drug Therapy, Combination; Elephantiasis, Filarial; Filaricides; Humans; Ivermectin; Lymphedema; Male; Papua New Guinea; Prospective Studies; Testicular Hydrocele; Wuchereria bancrofti | 2002 |
Doxycycline as a novel strategy against bancroftian filariasis-depletion of Wolbachia endosymbionts from Wuchereria bancrofti and stop of microfilaria production.
Topics: Adolescent; Adult; Animals; Anti-Bacterial Agents; Doxycycline; Elephantiasis, Filarial; Female; Filaricides; Ghana; Humans; Ivermectin; Male; Microfilariae; Middle Aged; Parasitemia; Symbiosis; Wolbachia; Wuchereria bancrofti | 2003 |
The impact of six rounds of single-dose mass administration of diethylcarbamazine or ivermectin on the transmission of Wuchereria bancrofti by Culex quinquefasciatus and its implications for lymphatic filariasis elimination programmes.
Topics: Animals; Culex; Diethylcarbamazine; Double-Blind Method; Drug Administration Schedule; Elephantiasis, Filarial; Filaricides; Humans; Insect Vectors; Ivermectin; Rural Health; Wuchereria bancrofti | 2003 |
Effects of ivermectin and diethylcarbamazine on microfilariae and overall microfilaria production in bancroftian filariasis.
Topics: Adult; Animals; Diethylcarbamazine; Double-Blind Method; Drug Therapy, Combination; Elephantiasis, Filarial; Female; Filaricides; Humans; Ivermectin; Male; Microfilariae; Models, Biological; Treatment Outcome; Wuchereria bancrofti | 2005 |
Tolerability and efficacy of single dose diethylcarbamazine (DEC) alone or co-administration with Ivermectin in the clearance of Wuchereria bancrofti microfilaraemia in Pondicherry, South India.
Topics: Adolescent; Adult; Animals; Antiparasitic Agents; Diethylcarbamazine; Double-Blind Method; Drug Therapy, Combination; Elephantiasis, Filarial; Female; Filaricides; Humans; India; Ivermectin; Male; Microfilariae; Parasitemia; Treatment Outcome; Wuchereria bancrofti | 2004 |
Impact of single dose of diethylcarbamazine and other antifilarial drug combinations on bancroftian filarial infection variables: assessment after 2 years.
Topics: Albendazole; Animals; Diethylcarbamazine; Drug Therapy, Combination; Elephantiasis, Filarial; Female; Filaricides; Humans; India; Ivermectin; Male; Rural Population; Wuchereria bancrofti | 2006 |
Filaria-induced monocyte dysfunction and its reversal following treatment.
Topics: Albendazole; Animals; Anthelmintics; Antiparasitic Agents; Drug Therapy, Combination; Elephantiasis, Filarial; Gene Expression; Heat-Shock Proteins; Humans; Ivermectin; Molecular Sequence Data; Monocytes; Treatment Outcome; Wuchereria bancrofti | 2006 |
Impact of 10 years of diethylcarbamazine and ivermectin mass administration on infection and transmission of lymphatic filariasis.
Topics: Animals; Child; Child, Preschool; Diethylcarbamazine; Double-Blind Method; Drug Administration Schedule; Elephantiasis, Filarial; Female; Filaricides; Humans; India; Infant; Ivermectin; Male; Preventive Health Services; Wuchereria bancrofti | 2007 |
Macrofilaricidal effect of 4 weeks of treatment with doxycycline on Wuchereria bancrofti.
Topics: Adolescent; Adult; Animals; Antigens, Helminth; Antiparasitic Agents; Doxycycline; Elephantiasis, Filarial; Ghana; Humans; Ivermectin; Male; Middle Aged; Treatment Outcome; Wuchereria bancrofti | 2007 |
Triple co-administration of ivermectin, albendazole and praziquantel in zanzibar: a safety study.
Topics: Adolescent; Adult; Albendazole; Anthelmintics; Child; Child, Preschool; Drug Therapy, Combination; Elephantiasis, Filarial; Female; Helminthiasis; Humans; Ivermectin; Male; Middle Aged; Onchocerciasis; Praziquantel; Tanzania; Young Adult | 2008 |
Mass drug administration trial to eliminate lymphatic filariasis in Papua New Guinea: changes in microfilaremia, filarial antigen, and Bm14 antibody after cessation.
Topics: Animals; Antibodies, Helminth; Antigens, Helminth; Antiparasitic Agents; Child; Child, Preschool; Diethylcarbamazine; Drug Therapy, Combination; Elephantiasis, Filarial; Follow-Up Studies; Humans; Infant; Ivermectin; Papua New Guinea; Wuchereria bancrofti | 2008 |
Side reactions following ivermectin therapy in high density bancroftian microfilaraemics.
Topics: Adolescent; Adult; Alkaline Phosphatase; Animals; Cough; Double-Blind Method; Elephantiasis, Filarial; Fever; Humans; Ivermectin; Male; Nausea; Pneumonia; Time Factors; Wuchereria bancrofti | 1993 |
Ivermectin plus diethylcarbamazine: an additive effect on early microfilarial clearance.
Topics: Animals; Carrier State; Diethylcarbamazine; Drug Therapy, Combination; Elephantiasis, Filarial; Humans; Ivermectin; Kinetics; Male; Microfilariae; Wuchereria bancrofti | 1994 |
Long-term efficacy of single-dose treatment with 400 micrograms.kg-1 of ivermectin in bancroftian filariasis: results at one year.
Topics: Animals; Diethylcarbamazine; Elephantiasis, Filarial; Female; Follow-Up Studies; Humans; Ivermectin; Male; Microfilariae; Recurrence; Wuchereria bancrofti | 1993 |
Ivermectin treatment of bancroftian filariasis in Recife, Brazil.
Topics: Adult; Animals; Brazil; Dose-Response Relationship, Drug; Double-Blind Method; Elephantiasis, Filarial; Eosinophilia; Fever; Follow-Up Studies; Hematuria; Humans; Ivermectin; Kinetics; Liver; Lung; Male; Microfilariae; Middle Aged; Military Personnel; Wuchereria bancrofti | 1994 |
Comparison of single-dose diethylcarbamazine and ivermectin for treatment of bancroftian filariasis in Papua New Guinea.
Topics: Adult; Animals; Antigens, Helminth; Diethylcarbamazine; Double-Blind Method; Elephantiasis, Filarial; Follow-Up Studies; Humans; Ivermectin; Lymph Nodes; Male; Microfilariae; Papua New Guinea; Wuchereria bancrofti | 1993 |
A comparative study of the efficacy and tolerability of single and split doses of ivermectin and diethylcarbamazine in periodic brugian filariasis.
Topics: Adolescent; Adult; Animals; Brugia; Diethylcarbamazine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Elephantiasis, Filarial; Humans; Ivermectin; Male; Microfilariae; Middle Aged; Periodicity; Time Factors | 1993 |
Ivermectin in the treatment of bancroftian filarial infection in Orissa, India.
Topics: Adult; Animals; Double-Blind Method; Elephantiasis, Filarial; Humans; India; Ivermectin; Male; Wuchereria bancrofti | 1993 |
Safety trial of single-dose treatments with a combination of ivermectin and diethylcarbamazine in bancroftian filariasis.
Topics: Adult; Aged; Animals; Carrier State; Diethylcarbamazine; Dose-Response Relationship, Drug; Drug Combinations; Elephantiasis, Filarial; Humans; Ivermectin; Male; Microfilariae; Middle Aged; Time Factors; Wuchereria bancrofti | 1993 |
[Efficacy of ivermectin for control of microfilaremia recurring after treatment with diethylcarbamazine: immunological observation].
Topics: Animals; Antibodies, Helminth; Antigens, Helminth; Diethylcarbamazine; Double-Blind Method; Elephantiasis, Filarial; Humans; Ivermectin; Wuchereria bancrofti | 1993 |
Comparative efficacy of clearing-dose and single high-dose ivermectin and diethylcarbamazine against Wuchereria bancrofti microfilaremia.
Topics: Adolescent; Adult; Aged; Animals; Circadian Rhythm; Diethylcarbamazine; Double-Blind Method; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; Drug Tolerance; Elephantiasis, Filarial; Female; Humans; Ivermectin; Male; Microfilariae; Middle Aged; Wuchereria bancrofti | 1993 |
Single doses of ivermectin 400 micrograms/kg-1: the most effective dosage in bancroftian filariasis.
Topics: Adult; Animals; Antinematodal Agents; Double-Blind Method; Elephantiasis, Filarial; Follow-Up Studies; Humans; Ivermectin; Middle Aged; Polynesia; Recurrence; Wuchereria bancrofti | 1995 |
[Combinations of ivermectin and diethylcarbamazine for improved control of lymphatic filariasis].
Topics: Adult; Aged; Communicable Disease Control; Diethylcarbamazine; Double-Blind Method; Drug Therapy, Combination; Elephantiasis, Filarial; Filaricides; Humans; Ivermectin; Male; Middle Aged; Time Factors | 1996 |
Randomised community-based trial of annual single-dose diethylcarbamazine with or without ivermectin against Wuchereria bancrofti infection in human beings and mosquitoes.
Topics: Adolescent; Adult; Animals; Anopheles; Child; Child, Preschool; Diethylcarbamazine; Drug Administration Schedule; Drug Therapy, Combination; Elephantiasis, Filarial; Female; Filaricides; Humans; Insect Vectors; Ivermectin; Male; Papua New Guinea; Wuchereria bancrofti | 1998 |
Prevention of acute adenolymphangitis in brugian filariasis: comparison of the efficacy of ivermectin and diethylcarbamazine, each combined with local treatment of the affected limb.
Topics: Acute Disease; Adult; Animals; Antinematodal Agents; Brugia malayi; Diethylcarbamazine; Double-Blind Method; Elephantiasis, Filarial; Female; Humans; Ivermectin; Lymphangitis; Male | 1998 |
Assessment of combined ivermectin and albendazole for treatment of intestinal helminth and Wuchereria bancrofti infections in Haitian schoolchildren.
Topics: Albendazole; Animals; Anthelmintics; Ascariasis; Body Height; Child; Child, Preschool; Double-Blind Method; Drug Therapy, Combination; Elephantiasis, Filarial; Female; Haiti; Helminthiasis; Hookworm Infections; Humans; Intestinal Diseases, Parasitic; Ivermectin; Male; Nutrition Assessment; Prevalence; Trichuriasis; Wuchereria bancrofti | 1999 |
Treatment of the microfilaraemia of asymptomatic brugian filariasis with single doses of ivermectin, diethylcarbamazine or albendazole, in various combinations.
Topics: Adolescent; Adult; Aged; Albendazole; Animals; Brugia malayi; Diethylcarbamazine; Drug Administration Schedule; Drug Therapy, Combination; Elephantiasis, Filarial; Female; Filaricides; Humans; Ivermectin; Male; Microfilariae; Middle Aged; Parasitemia; Treatment Outcome | 1999 |
[Efficacy of ivermectin for control of microfilaremia recurring after treatment with diethylcarbamazine. I. Clinical and parasitological observations].
Topics: Adolescent; Adult; Aged; Animals; Diethylcarbamazine; Double-Blind Method; Elephantiasis, Filarial; Female; Fever; Humans; Ivermectin; Male; Microfilariae; Middle Aged; Recurrence; Wuchereria bancrofti | 1992 |
[Ivermectin or diethylcarbamazine in spaced dosages in Bancroft's filariasis: which protocol?].
Topics: Adolescent; Adult; Animals; Diethylcarbamazine; Double-Blind Method; Drug Administration Schedule; Elephantiasis, Filarial; Humans; Ivermectin; Male; Middle Aged; Wuchereria bancrofti | 1992 |
Compared efficacy of repeated annual and semi-annual doses of ivermectin and diethylcarbamazine for prevention of Wuchereria bancrofti filariasis in French Polynesia. Final evaluation.
Topics: Adult; Animals; Carrier State; Diethylcarbamazine; Double-Blind Method; Drug Evaluation; Elephantiasis, Filarial; Follow-Up Studies; Humans; Ivermectin; Microfilariae; Middle Aged; Polynesia; Wuchereria bancrofti | 1992 |
Kinetics of circulating human IgG4 after diethylcarbamazine and ivermectin treatment of bancroftian filariasis.
Topics: Animals; Diethylcarbamazine; Elephantiasis, Filarial; Follow-Up Studies; Humans; Immunoglobulin G; Ivermectin; Kinetics; Microfilariae; Wuchereria bancrofti | 1992 |
Single versus repeated doses of ivermectin and diethylcarbamazine for the treatment of Wuchereria bancrofti var. pacifica microfilaremia. Results at 12 months of a double-blind study.
Topics: Adult; Animals; Carrier State; Diethylcarbamazine; Double-Blind Method; Drug Administration Schedule; Elephantiasis, Filarial; Humans; Ivermectin; Microfilariae; Middle Aged; Wuchereria bancrofti | 1991 |
Cumulative mortality rates in Aedes polynesiensis after feeding on polynesian Wuchereria bancrofti carriers treated with single doses of ivermectin, diethylcarbamazine and placebo.
Topics: Aedes; Animals; Carrier State; Diethylcarbamazine; Double-Blind Method; Elephantiasis, Filarial; Humans; Insect Vectors; Ivermectin; Probability; Wuchereria bancrofti | 1991 |
Efficacy of ivermectin for control of microfilaremia recurring after treatment with diethylcarbamazine. I. Clinical and parasitologic observations.
Topics: Adolescent; Adult; Animals; Diethylcarbamazine; Double-Blind Method; Elephantiasis, Filarial; Female; Humans; Ivermectin; Male; Microfilariae; Middle Aged; Recurrence; Wuchereria bancrofti | 1991 |
The treatment of microfilaremia due to Wuchereria bancrofti var. pacifica: ivermectin versus diethylcarbamazine.
Topics: Adolescent; Adult; Animals; Diethylcarbamazine; Elephantiasis, Filarial; Humans; Ivermectin; Male; Middle Aged; Polynesia; Wuchereria bancrofti | 1991 |
Comparison of high dose ivermectin and diethylcarbamazine for activity against bancroftian filariasis in Haiti.
Topics: Adolescent; Adult; Animals; Diethylcarbamazine; Double-Blind Method; Drug Tolerance; Elephantiasis, Filarial; Female; Follow-Up Studies; Haiti; Humans; Ivermectin; Male; Microfilariae; Middle Aged; Wuchereria bancrofti | 1991 |
Double blind study on efficacy and safety of single doses of ivermectin and diethylcarbamazine for treatment of Polynesian Wuchereria bancrofti carriers. Results at six months.
Topics: Adult; Animals; Carrier State; Diethylcarbamazine; Dose-Response Relationship, Drug; Double-Blind Method; Elephantiasis, Filarial; Humans; Ivermectin; Male; Microfilariae; Middle Aged; Wuchereria bancrofti | 1991 |
A controlled trial of ivermectin and diethylcarbamazine in lymphatic filariasis.
Topics: Adult; Animals; Diethylcarbamazine; Double-Blind Method; Drug Administration Schedule; Elephantiasis, Filarial; Filariasis; Humans; Ivermectin; Male; Middle Aged; Randomized Controlled Trials as Topic; Wuchereria bancrofti | 1990 |
Ivermectin for treatment of bancroftian filariasis in French Polynesia: efficacy in man, effect on transmission by vector Aedes polynesiensis.
Topics: Adult; Aedes; Animals; Elephantiasis, Filarial; Humans; Insect Vectors; Ivermectin; Larva; Male; Microfilariae; Middle Aged; Polynesia; Recurrence; Wuchereria bancrofti | 1990 |
Dose-ranging study of ivermectin in treatment of filariasis due to Wuchereria bancrofti.
Topics: Adult; Dose-Response Relationship, Drug; Elephantiasis, Filarial; Follow-Up Studies; Humans; Ivermectin; Male; Microfilariae; Wuchereria bancrofti | 1987 |
161 other study(ies) available for dextrothyroxine and Elephantiasis, Filarial
| Article | Year |
|---|---|
Assessing factors influencing communities' acceptability of mass drug administration for the elimination of lymphatic filariasis in Guyana.
Topics: Albendazole; Community Health Services; Cross-Sectional Studies; Data Collection; Diethylcarbamazine; Disease Eradication; Drug Combinations; Elephantiasis, Filarial; Guyana; Humans; Ivermectin; Mass Drug Administration; Patient Acceptance of Health Care; Sentinel Surveillance; Surveys and Questionnaires | 2021 |
Impact of Annual versus Semiannual Mass Drug Administration with Ivermectin and Albendazole on Helminth Infections in Southeastern Liberia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Albendazole; Antigens, Helminth; Child; Child, Preschool; Cross-Sectional Studies; Elephantiasis, Filarial; Female; Helminthiasis; Hookworm Infections; Humans; Ivermectin; Liberia; Male; Mass Drug Administration; Middle Aged; Prevalence; Trichuriasis; Young Adult | 2021 |
Lymphatic filariasis elimination status: Wuchereria bancrofti infections in human populations and factors contributing to continued transmission after seven rounds of mass drug administration in Masasi District, Tanzania.
Topics: Adolescent; Adult; Aged; Albendazole; Animals; Antigens, Helminth; Cross-Sectional Studies; Disease Eradication; Elephantiasis, Filarial; Female; Filaricides; Humans; Ivermectin; Male; Mass Drug Administration; Middle Aged; Prevalence; Tanzania; Wuchereria bancrofti | 2022 |
Costs of mass drug administration for scabies in Fiji.
Topics: Elephantiasis, Filarial; Fiji; Humans; Ivermectin; Mass Drug Administration; Neglected Diseases; Scabies | 2022 |
Lessons Learned from the Japanese Encephalitis Vaccine Introduction in India That Supported the Introduction of Ivermectin-Diethylcarbamazine-Albendazole for Lymphatic Filariasis Elimination.
Topics: Albendazole; Diethylcarbamazine; Elephantiasis, Filarial; Encephalitis, Japanese; Filaricides; Humans; India; Ivermectin; Japanese Encephalitis Vaccines | 2022 |
Accelerating the Uptake of WHO Recommendations for Mass Drug Administration Using Ivermectin, Diethylcarbamazine, and Albendazole.
Topics: Albendazole; Diethylcarbamazine; Drug Therapy, Combination; Elephantiasis, Filarial; Filaricides; Humans; Ivermectin; Mass Drug Administration; World Health Organization | 2022 |
The Importance of Partnership in the Rollout of Triple-Drug Therapy to Eliminate Lymphatic Filariasis in the Pacific.
Topics: Albendazole; Diethylcarbamazine; Drug Therapy, Combination; Elephantiasis, Filarial; Filaricides; Humans; Ivermectin | 2022 |
Introduction of Triple-Drug Therapy for Accelerating Lymphatic Filariasis Elimination in India: Lessons Learned.
Topics: Albendazole; Diethylcarbamazine; Elephantiasis, Filarial; Filaricides; Humans; India; Ivermectin | 2022 |
Country Reports on Practical Aspects of Conducting Large-Scale Community Studies of the Tolerability of Mass Drug Administration with Ivermectin/Diethylcarbamazine/Albendazole for Lymphatic Filariasis.
Topics: Albendazole; Diethylcarbamazine; Drug Therapy, Combination; Elephantiasis, Filarial; Filaricides; Humans; Ivermectin; Mass Drug Administration | 2022 |
Lessons from Large-Scale Tolerability and Acceptability Studies of Triple Drug Mass Drug Administration Performed to Support Policy Change and Accelerate Elimination of Lymphatic Filariasis.
Topics: Albendazole; Diethylcarbamazine; Drug Therapy, Combination; Elephantiasis, Filarial; Filaricides; Humans; Ivermectin; Mass Drug Administration; Pharmaceutical Preparations; Policy | 2022 |
Compressing the Timelines for Development and Delivery: Accelerating Access to Triple-Drug Therapy to Eliminate Lymphatic Filariasis.
Topics: Albendazole; Diethylcarbamazine; Drug Therapy, Combination; Elephantiasis, Filarial; Filaricides; Health Promotion; Humans; Ivermectin | 2022 |
Filariasis presenting as pancytopenia in a child.
Topics: Albendazole; Animals; Child; Diethylcarbamazine; Drug Therapy, Combination; Elephantiasis, Filarial; Female; Filaricides; Humans; Ivermectin; Pancytopenia; Wuchereria bancrofti | 2022 |
Integrated transmission assessment surveys (iTAS) of lymphatic filariasis and onchocerciasis in Cross River, Taraba and Yobe States, Nigeria.
Topics: Albendazole; Child; Child, Preschool; Elephantiasis, Filarial; Humans; Ivermectin; Nigeria; Onchocerciasis; Prevalence | 2022 |
Modelling lymphatic filariasis elimination in American Samoa: GEOFIL predicts need for new targets and six rounds of mass drug administration.
Topics: Albendazole; American Samoa; Animals; Child; Diethylcarbamazine; Elephantiasis, Filarial; Filaricides; Humans; Ivermectin; Mass Drug Administration; Prevalence | 2022 |
Step towards elimination of Wuchereria bancrofti in Southwest Tanzania 10 years after mass drug administration with Albendazole and Ivermectin.
Topics: Albendazole; Animals; Antigens, Helminth; Elephantiasis, Filarial; Filaricides; Follow-Up Studies; Humans; Ivermectin; Male; Mass Drug Administration; Tanzania; Wuchereria bancrofti | 2022 |
No evidence of lymphatic filariasis transmission in Bamako urban setting after three mass drug administration rounds.
Topics: Albendazole; Animals; Cross-Sectional Studies; Elephantiasis, Filarial; Filaricides; Humans; Immunoglobulin G; Ivermectin; Mass Drug Administration; Microfilariae; Mosquito Vectors; Prevalence; Wuchereria bancrofti | 2022 |
Comparing antigenaemia- and microfilaraemia as criteria for stopping decisions in lymphatic filariasis elimination programmes in Africa.
Topics: Africa; Albendazole; Animals; Elephantiasis, Filarial; Filaricides; Ivermectin; Prevalence; Wuchereria bancrofti | 2022 |
[Evaluation of therapeutic coverage of mass treatment campaign against lymphatic filariasis in two health districts in Burkina Faso].
Topics: Adolescent; Albendazole; Burkina Faso; Elephantiasis, Filarial; Female; Humans; Ivermectin; Male; Mass Drug Administration | 2022 |
Population pharmacokinetic model of ivermectin in mass drug administration against lymphatic filariasis.
Topics: Albendazole; Animals; Elephantiasis, Filarial; Female; Filaricides; Ivermectin; Mass Drug Administration; Wuchereria bancrofti | 2023 |
Comparative Safety Surveillance of Triple (IDA) Versus Dual Therapy (DA) in Mass Drug Administration for Elimination of Lymphatic Filariasis in Kenya: A Cohort Event Monitoring Study.
Topics: Albendazole; Diethylcarbamazine; Drug Therapy, Combination; Elephantiasis, Filarial; Female; Humans; Ivermectin; Kenya; Male; Mass Drug Administration | 2023 |
Scabies prevalence after ivermectin-based mass drug administration for lymphatic filariasis, Samoa 2018-2019.
Topics: Child; Child, Preschool; Elephantiasis, Filarial; Female; Humans; Ivermectin; Mass Drug Administration; Prevalence; Samoa; Scabies | 2023 |
Pharmacokinetics of Moxidectin combined with Albendazole or Albendazole plus Diethylcarbamazine for Bancroftian Filariasis.
Topics: Albendazole; Diethylcarbamazine; Elephantiasis, Filarial; Female; Humans; Ivermectin; Macrolides; Male | 2023 |
Integrated Prevalence Assessment of Wuchereria bancrofti and Onchocerca volvulus in Three Co-Endemic Districts of Gambella Region, Ethiopia.
Topics: Albendazole; Animals; Antigens, Helminth; Child; Elephantiasis, Filarial; Ethiopia; Female; Humans; Ivermectin; Male; Neglected Diseases; Onchocerca volvulus; Prevalence; Wuchereria bancrofti | 2023 |
Potential mitigating role of ivermectin on the spread of Chlamydia trachomatis by Musca sorbens.
Topics: Animals; Anti-Bacterial Agents; Azithromycin; Chlamydia trachomatis; Elephantiasis, Filarial; Humans; Ivermectin; Muscidae; Onchocerciasis; Trachoma | 2023 |
Progress towards the implementation of control programmes for strongyloidiasis in endemic areas: estimation of number of adults in need of ivermectin for strongyloidiasis.
Topics: Adult; Child; Elephantiasis, Filarial; Humans; Ivermectin; Onchocerciasis; Prevalence; Strongyloidiasis | 2024 |
Progress towards lymphatic filariasis elimination in Ghana from 2000-2016: Analysis of microfilaria prevalence data from 430 communities.
Topics: Albendazole; Animals; Child; Child, Preschool; Disease Eradication; Elephantiasis, Filarial; Endemic Diseases; Female; Ghana; Health Services Research; Humans; Ivermectin; Male; Mass Drug Administration; Microfilariae; Prevalence; Surveys and Questionnaires; World Health Organization | 2019 |
The division of labour between community medicine distributors influences the reach of mass drug administration: A cross-sectional study in rural Uganda.
Topics: Adolescent; Adult; Aged; Albendazole; Animals; Anthelmintics; Child; Child, Preschool; Community Health Workers; Community Medicine; Cross-Sectional Studies; Elephantiasis, Filarial; Female; Humans; Infant; Ivermectin; Male; Mass Drug Administration; Middle Aged; Neglected Diseases; Praziquantel; Rural Population; Schistosomiasis mansoni; Uganda; Young Adult | 2019 |
Frequency and Clinical Significance of Localized Adverse Events following Mass Drug Administration for Lymphatic Filariasis in an Endemic Area in South India.
Topics: Adolescent; Adult; Albendazole; Anthelmintics; Diethylcarbamazine; Drug Therapy, Combination; Elephantiasis, Filarial; Female; Humans; India; Ivermectin; Male; Mass Drug Administration | 2020 |
Are census data accurate for estimating coverage of a lymphatic filariasis MDA campaign? Results of a survey in Sierra Leone.
Topics: Adult; Albendazole; Censuses; Chemoprevention; Elephantiasis, Filarial; Female; Filaricides; Helminthiasis; Humans; Ivermectin; Male; Mass Drug Administration; Neglected Diseases; Onchocerciasis; Sierra Leone; Surveys and Questionnaires | 2019 |
Lymphedema in three previously Wuchereria bancrofti-endemic health districts in Mali after cessation of mass drug administration.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Albendazole; Animals; Child; Child, Preschool; Cross-Sectional Studies; Elephantiasis, Filarial; Endemic Diseases; Female; Humans; Ivermectin; Lymphedema; Male; Mali; Mass Drug Administration; Middle Aged; Morbidity; Prevalence; Public Health; Withholding Treatment; Wuchereria bancrofti; Young Adult | 2020 |
Challenges to Making the Decision to Stop Mass Drug Administration for Onchocerciasis: Lessons Learned from Nigeria.
Topics: Elephantiasis, Filarial; Humans; Ivermectin; Mass Drug Administration; Nigeria; Onchocerciasis | 2020 |
Serological Evaluation of Onchocerciasis and Lymphatic Filariasis Elimination in the Bakoye and Falémé Foci, Mali.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Elephantiasis, Filarial; Humans; Ivermectin; Mali; Middle Aged; Onchocerciasis; Seroepidemiologic Studies; Young Adult | 2021 |
Post-Treatment Surveillance for Lymphatic Filariasis in Plateau and Nasarawa States, Nigeria: Results of Transmission Assessment Surveys.
Topics: Albendazole; Anthelmintics; Child; Child, Preschool; Elephantiasis, Filarial; Female; Filaricides; Humans; Ivermectin; Male; Mass Drug Administration; Nigeria; Population Surveillance; Retrospective Studies | 2020 |
Mapping lymphatic filariasis in Loa loa endemic health districts naïve for ivermectin mass administration and situated in the forested zone of Cameroon.
Topics: Adolescent; Adult; Animals; Antigens, Helminth; Cameroon; Cross Reactions; Cross-Sectional Studies; Elephantiasis, Filarial; Female; Forests; Humans; Immunoassay; Ivermectin; Loa; Male; Mass Drug Administration; Middle Aged; Prevalence; Real-Time Polymerase Chain Reaction; Wuchereria bancrofti; Young Adult | 2020 |
Single-Dose Triple-Drug Therapy for
Topics: Albendazole; Animals; Antigens, Helminth; Diethylcarbamazine; Drug Therapy, Combination; Elephantiasis, Filarial; Female; Filaricides; Follow-Up Studies; Humans; Ivermectin; Male; Parasite Load; Wuchereria bancrofti | 2020 |
Designing antifilarial drug trials using clinical trial simulators.
Topics: Clinical Trial Protocols as Topic; Clinical Trials as Topic; Computer Simulation; Drug Evaluation; Elephantiasis, Filarial; Filaricides; Humans; Ivermectin; Models, Biological; Onchocerciasis | 2020 |
Predicting lymphatic filariasis elimination in data-limited settings: A reconstructive computational framework for combining data generation and model discovery.
Topics: Antigens, Helminth; Computational Biology; Databases, Factual; Disease Eradication; Elephantiasis, Filarial; Filaricides; Humans; Ivermectin; Models, Biological; Models, Statistical; Nigeria | 2020 |
Impact of annual and semi-annual mass drug administration for Lymphatic Filariasis and Onchocerciasis on Hookworm Infection in Côte d'Ivoire.
Topics: Adolescent; Adult; Albendazole; Ancylostomatoidea; Animals; Child; Cote d'Ivoire; Cross-Sectional Studies; Drug Combinations; Elephantiasis, Filarial; Female; Hookworm Infections; Humans; Ivermectin; Male; Mass Drug Administration; Middle Aged; Onchocerciasis; Prevalence; Young Adult | 2020 |
A community survey of coverage and adverse events following country-wide triple-drug mass drug administration for lymphatic filariasis elimination, Samoa 2018.
Topics: Albendazole; Animals; Diethylcarbamazine; Drug Therapy, Combination; Elephantiasis, Filarial; Female; Filaricides; Humans; Ivermectin; Male; Mass Drug Administration; Program Evaluation; Samoa; Wuchereria bancrofti | 2020 |
Ivermectin inhibits extracellular vesicle secretion from parasitic nematodes.
Topics: Animals; Antiparasitic Agents; Brugia malayi; Elephantiasis, Filarial; Extracellular Vesicles; Female; Gastrointestinal Tract; Helminth Proteins; Ivermectin; Locomotion; Male; Microfilariae; Phagocytosis | 2020 |
A triple-drug treatment regimen to accelerate elimination of lymphatic filariasis: From conception to delivery.
Topics: Albendazole; Diethylcarbamazine; Drug Therapy, Combination; Elephantiasis, Filarial; Filaricides; Humans; Ivermectin; Pharmaceutical Preparations | 2020 |
Achievements and challenges of lymphatic filariasis elimination in Sierra Leone.
Topics: Albendazole; Animals; Brugia malayi; Child; Child, Preschool; Disease Eradication; Elephantiasis, Filarial; Filaricides; Humans; Ivermectin; Mass Drug Administration; Sierra Leone; Wuchereria bancrofti | 2020 |
Implementation challenges and opportunities for improved mass treatment uptake for lymphatic filariasis elimination: Perceptions and experiences of community drug distributors of coastal Kenya.
Topics: Adolescent; Adult; Aged; Albendazole; Animals; Anthelmintics; Brugia malayi; Diethylcarbamazine; Elephantiasis, Filarial; Female; Health Education; Health Knowledge, Attitudes, Practice; Humans; Ivermectin; Kenya; Male; Mass Drug Administration; Medication Systems; Middle Aged; Patient Compliance; Treatment Refusal; Wuchereria bancrofti; Young Adult | 2020 |
Effect of 3 years of biannual mass drug administration with albendazole on lymphatic filariasis and soil-transmitted helminth infections: a community-based study in Republic of the Congo.
Topics: Adolescent; Adult; Albendazole; Animals; Anthelmintics; Antiparasitic Agents; Child; Elephantiasis, Filarial; Feces; Female; Helminthiasis; Humans; Ivermectin; Loiasis; Male; Soil; Time Factors | 2017 |
Lymphatic filariasis elimination efforts in Rufiji, southeastern Tanzania: decline in circulating filarial antigen prevalence in young school children after twelve rounds of mass drug administration and utilization of long-lasting insecticide-treated nets
Topics: Albendazole; Animals; Child; Cross-Sectional Studies; Diethylcarbamazine; Disease Eradication; Elephantiasis, Filarial; Family Characteristics; Female; Filaricides; Humans; Insecticides; Ivermectin; Male; Mass Drug Administration; Prevalence; Surveys and Questionnaires; Tanzania; Wuchereria bancrofti | 2017 |
First evidence of lymphatic filariasis transmission interruption in Cameroon: Progress towards elimination.
Topics: Albendazole; Animals; Antigens, Helminth; Cameroon; Child; Child, Preschool; Chromatography, Affinity; Communicable Disease Control; Disease Eradication; Disease Transmission, Infectious; Elephantiasis, Filarial; Female; Filaricides; Health Services Administration; Humans; Ivermectin; Male; Wuchereria bancrofti | 2017 |
Side Benefits of Mass Drug Administration for Lymphatic Filariasis on
Topics: Animals; Anthelmintics; Elephantiasis, Filarial; Humans; Islands; Ivermectin; Prevalence; Retrospective Studies; Strongyloides stercoralis; Strongyloidiasis; Tanzania | 2017 |
Criteria to Stop Mass Drug Administration for Lymphatic Filariasis Have Been Achieved Throughout Plateau and Nasarawa States, Nigeria.
Topics: Albendazole; Anthelmintics; Antigens, Helminth; Child; Chromatography, Affinity; Elephantiasis, Filarial; Humans; Ivermectin; Nigeria; Population Surveillance | 2017 |
An evaluation of Wb123 antibody elisa in individuals treated with ivermectin and albendazole, and implementation challenges in Africa.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Albendazole; Animals; Anthelmintics; Antibodies, Helminth; Antigens, Helminth; Child; Chromatography, Affinity; Cross-Sectional Studies; Elephantiasis, Filarial; Enzyme-Linked Immunosorbent Assay; Humans; Ivermectin; Middle Aged; Wuchereria bancrofti; Young Adult | 2017 |
Twelve-month longitudinal parasitological assessment of lymphatic filariasis-positive individuals: impact of a biannual treatment with ivermectin and albendazole.
Topics: Adolescent; Adult; Aged; Albendazole; Animals; Antigens, Helminth; Child; Elephantiasis, Filarial; Female; Filaricides; Filarioidea; Ghana; Government Programs; Humans; Ivermectin; Longitudinal Studies; Male; Microfilariae; Middle Aged; Prevalence; Young Adult | 2017 |
Global programme to eliminate lymphatic filariasis: progress report, 2016.
Topics: Albendazole; Anthelmintics; Diethylcarbamazine; Disease Eradication; Drug Therapy, Combination; Elephantiasis, Filarial; Endemic Diseases; Global Health; Humans; Ivermectin; Loiasis; Neglected Diseases; Onchocerciasis; Program Evaluation | 2017 |
A Test-and-Not-Treat Strategy for Onchocerciasis in Loa loa-Endemic Areas.
Topics: Adolescent; Adult; Aged; Animals; Antiparasitic Agents; Blood; Cameroon; Child; Elephantiasis, Filarial; Endemic Diseases; Female; Humans; Ivermectin; Loa; Logistic Models; Loiasis; Male; Microfilariae; Microscopy, Video; Middle Aged; Onchocerciasis | 2017 |
For as Long as Necessary: Examining 30 years of MSD's Focus on Achieving Elimination of Onchocerciasis and Lymphatic Filariasis.
Topics: Africa; Antiparasitic Agents; Disease Eradication; Drug Industry; Elephantiasis, Filarial; Global Health; Humans; Ivermectin; Latin America; Onchocerciasis | 2018 |
The interruption of Onchocerca volvulus and Wuchereria bancrofti transmission by integrated chemotherapy in the Obongi focus, North Western Uganda.
Topics: Adolescent; Albendazole; Animals; Antiparasitic Agents; Child; Child, Preschool; Elephantiasis, Filarial; Enzyme-Linked Immunosorbent Assay; Female; Humans; Immunoglobulin G; Ivermectin; Male; Onchocerca volvulus; Onchocerciasis; Prevalence; Uganda; Wuchereria bancrofti | 2017 |
Geographical distribution and species identification of human filariasis and onchocerciasis in Bioko Island, Equatorial Guinea.
Topics: Adolescent; Adult; Animals; Antiparasitic Agents; Child; Child, Preschool; Cross-Sectional Studies; Elephantiasis, Filarial; Equatorial Guinea; Female; Geographic Mapping; Humans; Infection Control; Ivermectin; Male; Mansonella; Mansonelliasis; Microfilariae; Middle Aged; Onchocerca volvulus; Onchocerciasis; Prevalence; Reproducibility of Results; Sensitivity and Specificity; Skin; Young Adult | 2018 |
Identifying co-endemic areas for major filarial infections in sub-Saharan Africa: seeking synergies and preventing severe adverse events during mass drug administration campaigns.
Topics: Africa South of the Sahara; Albendazole; Animals; Diethylcarbamazine; Drug Synergism; Drug Therapy, Combination; Elephantiasis, Filarial; Female; Filaricides; Humans; Ivermectin; Loiasis; Male; Mass Drug Administration; Onchocerca; Onchocerciasis; Wuchereria bancrofti | 2018 |
Operationalization of the test and not treat strategy to accelerate the elimination of onchocerciasis and lymphatic filariasis in Central Africa.
Topics: Africa, Central; Animals; Antiparasitic Agents; Cameroon; Disease Eradication; Elephantiasis, Filarial; Humans; Ivermectin; Loiasis; Onchocerciasis | 2018 |
Profiling extracellular vesicle release by the filarial nematode Brugia malayi reveals sex-specific differences in cargo and a sensitivity to ivermectin.
Topics: Animals; Brugia malayi; Dirofilaria immitis; Dirofilariasis; Elephantiasis, Filarial; Extracellular Vesicles; Female; Humans; Ivermectin; Macrophages; Male; Mice; Microfilariae; Phagocytosis; Proteome; Proteomics | 2018 |
Are Alternative Strategies Required to Accelerate the Global Elimination of Lymphatic Filariasis? Insights From Mathematical Models.
Topics: Albendazole; Animals; Computer Simulation; Diethylcarbamazine; Disease Eradication; Drug Therapy, Combination; Elephantiasis, Filarial; Filaricides; Humans; Ivermectin; Mass Drug Administration; Microfilariae; Models, Theoretical | 2018 |
Progress on elimination of lymphatic filariasis in Sierra Leone.
Topics: Adolescent; Adult; Albendazole; Animals; Child; Disease Eradication; Elephantiasis, Filarial; Female; Filaricides; Humans; Ivermectin; Male; Mass Drug Administration; Sierra Leone; Wuchereria bancrofti; Young Adult | 2018 |
Evaluation of Treatment Coverage and Enhanced Mass Drug Administration for Onchocerciasis and Lymphatic Filariasis in Five Local Government Areas Treating Twice Per Year in Edo State, Nigeria.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Albendazole; Child; Disease Eradication; Drug Administration Schedule; Drug Therapy, Combination; Elephantiasis, Filarial; Female; Filaricides; Humans; Ivermectin; Local Government; Male; Mass Drug Administration; Middle Aged; Nigeria; Onchocerciasis; Prevalence; Surveys and Questionnaires; Treatment Outcome; Young Adult | 2018 |
Impact of Ivermectin Mass Drug Administration for Lymphatic Filariasis on Scabies in Eight Villages in Kongwa District, Tanzania.
Topics: Adolescent; Animals; Child; Child, Preschool; Cross-Sectional Studies; Drug Administration Schedule; Elephantiasis, Filarial; Female; Filaricides; Humans; Infant; Ivermectin; Male; Mass Drug Administration; Onchocerca; Onchocerciasis; Prevalence; Rural Population; Sarcoptes scabiei; Scabies; Tanzania; Wuchereria bancrofti | 2018 |
Impact of repeated annual community directed treatment with ivermectin on loiasis parasitological indicators in Cameroon: Implications for onchocerciasis and lymphatic filariasis elimination in areas co-endemic with Loa loa in Africa.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Animals; Antiparasitic Agents; Cameroon; Child; Cross-Sectional Studies; Elephantiasis, Filarial; Female; Humans; Ivermectin; Loiasis; Male; Mass Drug Administration; Middle Aged; Onchocerciasis; Prevalence; Treatment Outcome; Young Adult | 2018 |
Recognition and killing of Brugia malayi microfilariae by human immune cells is dependent on the parasite sample and is not altered by ivermectin treatment.
Topics: Animals; Brugia malayi; Diethylcarbamazine; Elephantiasis, Filarial; Filaricides; High-Throughput Nucleotide Sequencing; Humans; Ivermectin; Microfilariae; Monocytes; Neutrophils | 2018 |
Update on the current status of onchocerciasis in Côte d'Ivoire following 40 years of intervention: Progress and challenges.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Child, Preschool; Cote d'Ivoire; Disease Transmission, Infectious; Elephantiasis, Filarial; Endemic Diseases; Epidemiologic Studies; Female; Filaricides; Humans; Insect Control; Ivermectin; Male; Middle Aged; Onchocerciasis; Prevalence; Young Adult | 2018 |
Lymphatic filariasis transmission in Rufiji District, southeastern Tanzania: infection status of the human population and mosquito vectors after twelve rounds of mass drug administration.
Topics: Adolescent; Adult; Aged; Albendazole; Animals; Antiprotozoal Agents; Child; Culex; Elephantiasis, Filarial; Female; Filaricides; Humans; Ivermectin; Male; Mass Drug Administration; Middle Aged; Mosquito Vectors; Real-Time Polymerase Chain Reaction; Tanzania; Wuchereria bancrofti; Young Adult | 2018 |
Elimination within reach: A cross-sectional study highlighting the factors that contribute to persistent lymphatic filariasis in eight communities in rural Ghana.
Topics: Albendazole; Animals; Anopheles; Antigens, Helminth; Brugia malayi; Child; Child, Preschool; Cross-Sectional Studies; Diethylcarbamazine; Elephantiasis, Filarial; Female; Filaricides; Ghana; Humans; Ivermectin; Male; Mass Drug Administration; Microfilariae; Parasite Load; Risk Factors; Rural Population; Wuchereria bancrofti | 2019 |
First study of topical selamectin efficacy for treating cats naturally infected with Brugia malayi and Brugia pahangi under field conditions.
Topics: Animals; Antiparasitic Agents; Brugia malayi; Brugia pahangi; Cats; Chemoprevention; Elephantiasis, Filarial; Humans; Ivermectin; Microfilariae; Thailand | 2019 |
Wuchereria bancrofti-infected individuals harbor distinct IL-10-producing regulatory B and T cell subsets which are affected by anti-filarial treatment.
Topics: Adult; Aged; Aged, 80 and over; Albendazole; Animals; Anthelmintics; B-Lymphocytes, Regulatory; Elephantiasis, Filarial; Female; Ghana; Humans; Interleukin-10; Ivermectin; Male; Middle Aged; T-Lymphocytes, Regulatory; Th2 Cells; Wuchereria bancrofti; Young Adult | 2019 |
Assessment of treatment impact on lymphatic filariasis in 13 districts of Benin: progress toward elimination in nine districts despite persistence of transmission in some areas.
Topics: Albendazole; Animals; Antigens, Helminth; Benin; Child; Disease Eradication; Elephantiasis, Filarial; Female; Filaricides; Humans; Ivermectin; Male; Mass Drug Administration; Outcome Assessment, Health Care; Public Health; Surveys and Questionnaires; Treatment Outcome; Wuchereria bancrofti | 2019 |
Towards elimination of lymphatic filariasis: social mobilization issues and challenges in mass drug administration with anti-filarial drugs in Tamil Nadu, South India.
Topics: Albendazole; Animals; Community Health Services; Community Health Workers; Community Participation; Diethylcarbamazine; Disease Eradication; Drug Administration Schedule; Elephantiasis, Filarial; Endemic Diseases; Filaricides; Global Health; Health Policy; House Calls; Humans; India; Ivermectin; Medication Adherence; Microfilariae; National Health Programs; Preventive Health Services; Workforce | 2013 |
Scientists celebrate successes, new tools in fight against human parasitic worms.
Topics: Africa; Antiparasitic Agents; Blindness; Elephantiasis, Filarial; Humans; Ivermectin; Neglected Diseases; Onchocerciasis; Skin Diseases; Sudan | 2013 |
Lymphatic filariasis control in Tanzania: effect of six rounds of mass drug administration with ivermectin and albendazole on infection and transmission.
Topics: Adolescent; Albendazole; Animals; Child; Child, Preschool; Culicidae; Elephantiasis, Filarial; Filaricides; Humans; Insect Vectors; Ivermectin; Prevalence; Tanzania | 2013 |
Community-wide distribution of long-lasting insecticidal nets can halt transmission of lymphatic filariasis in southeastern Nigeria.
Topics: Animals; Anopheles; Child, Preschool; Elephantiasis, Filarial; Family Characteristics; Female; Humans; Insecticide-Treated Bednets; Insecticides; Ivermectin; Longitudinal Studies; Malaria; Mosquito Control; Nigeria; Pregnancy; Rural Population | 2013 |
Long-lasting insecticidal nets are synergistic with mass drug administration for interruption of lymphatic filariasis transmission in Nigeria.
Topics: Albendazole; Animals; Anopheles; Communicable Disease Control; Elephantiasis, Filarial; Filaricides; Humans; Insecticide-Treated Bednets; Insecticides; Ivermectin; Nigeria | 2013 |
A longitudinal analysis of the effect of mass drug administration on acute inflammatory episodes and disease progression in lymphedema patients in Leogane, Haiti.
Topics: Adolescent; Adult; Aged; Albendazole; Anthelmintics; Child; Diethylcarbamazine; Elephantiasis, Filarial; Female; Haiti; Humans; Inflammation; Ivermectin; Male; Middle Aged; Young Adult | 2014 |
Baseline drivers of lymphatic filariasis in Burkina Faso.
Topics: Agriculture; Albendazole; Anthelmintics; Burkina Faso; Climate; Elephantiasis, Filarial; Female; Humans; Ivermectin; Male; Population Density; Prevalence; Remote Sensing Technology; Risk Factors; Socioeconomic Factors | 2013 |
Meeting of the International Task Force for Disease Eradication, January 2014.
Topics: Advisory Committees; Africa; Albendazole; Anthelmintics; Disease Eradication; Elephantiasis, Filarial; Endemic Diseases; Humans; Insecticide-Treated Bednets; Ivermectin; Loiasis; Onchocerciasis, Ocular | 2014 |
Liquid chromatography-mass spectrometry analysis of diethylcarbamazine in human plasma for clinical pharmacokinetic studies.
Topics: Albendazole; Chromatography, Liquid; Diethylcarbamazine; Elephantiasis, Filarial; Humans; Ivermectin; Mass Spectrometry; Plasma; Solid Phase Extraction | 2014 |
Status of Onchocerciasis transmission after more than a decade of mass drug administration for onchocerciasis and lymphatic filariasis elimination in central Nigeria: challenges in coordinating the stop MDA decision.
Topics: Adult; Albendazole; Animals; Anthelmintics; Antibodies; Antiparasitic Agents; Child; Child, Preschool; Elephantiasis, Filarial; Female; Humans; Ivermectin; Male; Microfilariae; Middle Aged; Nigeria; Onchocerciasis; Prevalence; Seroepidemiologic Studies; Simuliidae; Young Adult | 2014 |
Factors influencing drug uptake during mass drug administration for control of lymphatic filariasis in rural and urban Tanzania.
Topics: Adolescent; Adult; Albendazole; Child; Child, Preschool; Cross-Sectional Studies; Elephantiasis, Filarial; Female; Humans; Ivermectin; Male; Patient Acceptance of Health Care; Rural Population; Tanzania; Urban Population; Young Adult | 2014 |
[Lymphatic filariasis transmission assessment survey in schools three years after stopping mass drug treatment with albendazole and ivermectin in the 7 endemic districts in Togo].
Topics: Albendazole; Animals; Anthelmintics; Antigens, Helminth; Child; Chromatography, Affinity; Cross-Sectional Studies; Elephantiasis, Filarial; Endemic Diseases; Female; Government Programs; Health Promotion; Health Surveys; Humans; Ivermectin; Male; Mass Screening; Microfilariae; Parasitemia; Practice Guidelines as Topic; Program Evaluation; Sampling Studies; School Health Services; Schools; Togo; World Health Organization; Wuchereria bancrofti | 2015 |
Repurposing auranofin as a lead candidate for treatment of lymphatic filariasis and onchocerciasis.
Topics: Adult; Albendazole; Animals; Anthelmintics; Auranofin; Brugia malayi; Cattle; Cell Line; Diethylcarbamazine; Drug Repositioning; Elephantiasis, Filarial; Female; Filaricides; Gerbillinae; Haplorhini; Humans; Ivermectin; Loa; Loiasis; Microfilariae; Onchocerca volvulus; Onchocerciasis | 2015 |
The Impact of Six Annual Rounds of Mass Drug Administration on Wuchereria bancrofti Infections in Humans and in Mosquitoes in Mali.
Topics: Adolescent; Adult; Albendazole; Animals; Child; Child, Preschool; Cross-Sectional Studies; Culicidae; Drug Therapy, Combination; Elephantiasis, Filarial; Female; Humans; Ivermectin; Larva; Male; Mali; Middle Aged; Prevalence; Wuchereria bancrofti; Young Adult | 2015 |
Onchocerciasis and lymphatic filariasis elimination in Africa: it's about time.
Topics: Africa; Albendazole; Animals; Anthelmintics; Antiparasitic Agents; Disease Eradication; Elephantiasis, Filarial; Humans; Ivermectin; Onchocerca volvulus; Onchocerciasis | 2015 |
Transmission indices and microfilariae prevalence in human population prior to mass drug administration with ivermectin and albendazole in the Gomoa District of Ghana.
Topics: Albendazole; Animals; Anopheles; Communicable Disease Control; Disease Transmission, Infectious; Elephantiasis, Filarial; Filaricides; Ghana; Humans; Insect Vectors; Ivermectin; Microfilariae; Patient Acceptance of Health Care; Prevalence | 2015 |
Accuracy of Coverage Survey Recall following an Integrated Mass Drug Administration for Lymphatic Filariasis, Schistosomiasis, and Soil-Transmitted Helminthiasis.
Topics: Adolescent; Adult; Albendazole; Antiparasitic Agents; Child; Elephantiasis, Filarial; Female; Helminthiasis; Humans; Ivermectin; Male; Mental Recall; Middle Aged; Praziquantel; Schistosomiasis; Soil; Togo; Young Adult | 2016 |
Presence of Wuchereria bancrofti microfilaremia despite 7 years of annual ivermectin monotherapy mass drug administration for onchocerciasis control: a study in north-west Ethiopia.
Topics: Adolescent; Adult; Age Distribution; Aged; Animals; Antiparasitic Agents; Child; Child, Preschool; Drug Administration Schedule; Drug Utilization; Elephantiasis, Filarial; Endemic Diseases; Ethiopia; Female; Humans; Ivermectin; Male; Microfilariae; Middle Aged; Onchocerciasis; Prevalence; Sex Distribution; Wuchereria bancrofti | 2015 |
Prevalence of Lymphatic Filariasis and Treatment Effectiveness of Albendazole/ Ivermectin in Individuals with HIV Co-infection in Southwest-Tanzania.
Topics: Albendazole; Animals; Antigens, Protozoan; Coinfection; Elephantiasis, Filarial; Filaricides; HIV Infections; Humans; Ivermectin; Prevalence; Tanzania; Treatment Outcome; Wuchereria bancrofti | 2016 |
Antifilarial activity of diterpenoids from Taxodium distichum.
Topics: Animals; Brugia malayi; Diethylcarbamazine; Disease Models, Animal; Diterpenes; Elephantiasis, Filarial; Female; Filaricides; Gerbillinae; Humans; Ivermectin; Male; Microfilariae; Murinae; Plant Components, Aerial; Plant Extracts; Taxodium | 2016 |
Mathematical modelling of lymphatic filariasis elimination programmes in India: required duration of mass drug administration and post-treatment level of infection indicators.
Topics: Albendazole; Animals; Computer Simulation; Culex; Diethylcarbamazine; Drug Administration Schedule; Elephantiasis, Filarial; Filaricides; Humans; India; Ivermectin; Models, Biological; National Health Programs; Rural Health; Wuchereria bancrofti | 2016 |
Recrudescence of onchocerciasis in the Comoé valley in Southwest Burkina Faso.
Topics: Animals; Antiparasitic Agents; Burkina Faso; Disease Outbreaks; Elephantiasis, Filarial; Environment; Humans; Infection Control; Insect Vectors; Ivermectin; Microfilariae; Onchocerciasis; Prevalence; Recurrence | 2017 |
Evaluation of Lymphatic Filariasis and Onchocerciasis in Three Senegalese Districts Treated for Onchocerciasis with Ivermectin.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Helminth; Child; Child, Preschool; Elephantiasis, Filarial; Female; Humans; Ivermectin; Male; Middle Aged; Onchocerciasis; Senegal; Treatment Outcome; Young Adult | 2016 |
The Impact of Lymphatic Filariasis Mass Drug Administration Scaling Down on Soil-Transmitted Helminth Control in School-Age Children. Present Situation and Expected Impact from 2016 to 2020.
Topics: Africa; Albendazole; Animals; Anthelmintics; Antinematodal Agents; Asia; Child; Diethylcarbamazine; Elephantiasis, Filarial; Female; Helminthiasis; Humans; Ivermectin; Male; National Health Programs; Prevalence; Schools; Soil; World Health Organization | 2016 |
Effectiveness of a triple-drug regimen for global elimination of lymphatic filariasis: a modelling study.
Topics: Albendazole; Animals; Anthelmintics; Antiparasitic Agents; Diethylcarbamazine; Drug Administration Schedule; Drug Therapy, Combination; Elephantiasis, Filarial; Filaricides; Global Health; Humans; Ivermectin; Models, Statistical | 2017 |
Potential Value of Triple Drug Therapy with Ivermectin, Diethylcarbamazine, and Albendazole (IDA) to Accelerate Elimination of Lymphatic Filariasis and Onchocerciasis in Africa.
Topics: Africa; Albendazole; Anthelmintics; Diethylcarbamazine; Drug Therapy, Combination; Elephantiasis, Filarial; Humans; Ivermectin; Onchocerciasis | 2017 |
The combined effect of the Lymphatic Filariasis Elimination Programme and the Schistosomiasis and Soil-transmitted Helminthiasis Control Programme on soil-transmitted helminthiasis in schoolchildren in Tanzania.
Topics: Albendazole; Animals; Anthelmintics; Child; Drug Therapy, Combination; Elephantiasis, Filarial; Female; Helminthiasis; Hookworm Infections; Humans; Intestinal Diseases, Parasitic; Ivermectin; Male; Parasite Egg Count; Praziquantel; Prevalence; Program Evaluation; Schistosomiasis; Soil; Tanzania | 2009 |
10 years of success in addressing lymphatic filariasis.
Topics: Albendazole; Anthelmintics; Elephantiasis, Filarial; Global Health; Humans; Ivermectin; Time Factors | 2009 |
A decade of ivermectin-albendazole donation for lymphatic filariasis.
Topics: Albendazole; Animals; Elephantiasis, Filarial; Endemic Diseases; Global Health; Humans; Ivermectin | 2009 |
GlaxoSmithKline and Merck: private-sector collaboration for the elimination of lymphatic filariasis.
Topics: Albendazole; Drug Industry; Elephantiasis, Filarial; Filaricides; Global Health; Humans; Ivermectin; Private Sector; Program Evaluation | 2009 |
The Global Programme to Eliminate Lymphatic Filariasis: health impact during its first 8 years (2000-2007).
Topics: Albendazole; Animals; Child; Communicable Disease Control; Disease Progression; Elephantiasis, Filarial; Filaricides; Global Health; Humans; Infant, Newborn; Infant, Newborn, Diseases; Ivermectin; Program Evaluation; Time Factors | 2009 |
Lymphatic filariasis control in Tanzania: effect of repeated mass drug administration with ivermectin and albendazole on infection and transmission.
Topics: Adolescent; Adult; Albendazole; Animals; Antigens, Helminth; Antiparasitic Agents; Child; Child, Preschool; Elephantiasis, Filarial; Female; Humans; Immunoglobulin G; Infant; Ivermectin; Male; Microfilariae; Middle Aged; Seasons; Tanzania | 2010 |
Post-kidney transplantation lymphocele due to a lymphatic filariasis.
Topics: Albendazole; Antiparasitic Agents; Doxycycline; Drainage; Elephantiasis, Filarial; Humans; Ivermectin; Kidney Failure, Chronic; Kidney Transplantation; Lymphocele; Male; Middle Aged; Postoperative Complications; Tomography, X-Ray Computed | 2010 |
Public-private partnerships in neglected tropical disease control: the role of nongovernmental organisations.
Topics: Animals; Communicable Disease Control; Elephantiasis, Filarial; Filaricides; Humans; Ivermectin; Neglected Diseases; Onchocerciasis; Organizations; Public-Private Sector Partnerships; Trachoma; Tropical Climate | 2011 |
Rapid community identification, pain and distress associated with lymphoedema and adenolymphangitis due to lymphatic filariasis in resource-limited communities of North-eastern Nigeria.
Topics: Adult; Community Health Services; Elephantiasis, Filarial; Female; Filaricides; Health Knowledge, Attitudes, Practice; Health Surveys; Humans; Ivermectin; Lymphadenitis; Lymphangitis; Lymphedema; Male; Middle Aged; Nigeria; Pain; Poverty Areas; Psychological Distance; Time Factors; Young Adult | 2011 |
Influence of anti-filarial chemotherapy strategies on the genetic structure of Wuchereria bancrofti populations.
Topics: Albendazole; Animals; Diethylcarbamazine; Drug Administration Schedule; Drug Therapy, Combination; Elephantiasis, Filarial; Filaricides; Genetic Variation; Humans; Ivermectin; Random Amplified Polymorphic DNA Technique; Wuchereria bancrofti | 2011 |
Flubendazole: a candidate macrofilaricide for lymphatic filariasis and onchocerciasis field programs.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Animals; Anthelmintics; beta-Cyclodextrins; Brugia; Chemistry, Pharmaceutical; Diethylcarbamazine; Drug Therapy, Combination; Elephantiasis, Filarial; Excipients; Filaricides; Humans; Ivermectin; Mebendazole; Onchocerca volvulus; Onchocerciasis | 2011 |
Simultaneous administration of praziquantel, ivermectin and albendazole, in a community in rural northern Ghana endemic for schistosomiasis, onchocerciasis and lymphatic filariasis.
Topics: Adolescent; Albendazole; Child; Drug Therapy, Combination; Elephantiasis, Filarial; Endemic Diseases; Female; Filaricides; Ghana; Health Education; Humans; Ivermectin; Male; Onchocerciasis; Praziquantel; Rural Population; Schistosomiasis | 2011 |
The impact of mass drug administration and long-lasting insecticidal net distribution on Wuchereria bancrofti infection in humans and mosquitoes: an observational study in northern Uganda.
Topics: Adolescent; Albendazole; Animals; Anopheles; Anthelmintics; Child; Child, Preschool; Elephantiasis, Filarial; Female; Humans; Insecticide-Treated Bednets; Insecticides; Ivermectin; Larva; Male; Mosquito Control; Uganda; Wuchereria bancrofti | 2011 |
Progress toward elimination of lymphatic filariasis--Togo, 2000--2009.
Topics: Adolescent; Adult; Aged; Albendazole; Animals; Antiparasitic Agents; Child; Child, Preschool; Chromatography; Community Health Services; Elephantiasis, Filarial; Female; Humans; Immunoassay; Ivermectin; Male; Middle Aged; Prevalence; Public Health; Sentinel Surveillance; Togo; Wuchereria bancrofti | 2011 |
Meeting of the International Task Force for Disease Eradication, April 2011.
Topics: Africa; Antiparasitic Agents; Biomedical Research; Comorbidity; Elephantiasis, Filarial; Endemic Diseases; Humans; Ivermectin; Loiasis; Onchocerciasis; Prevalence | 2011 |
Epidemiological and entomological evaluations after six years or more of mass drug administration for lymphatic filariasis elimination in Nigeria.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Albendazole; Animals; Antigens, Helminth; Child; Child, Preschool; Drug Therapy, Combination; Elephantiasis, Filarial; Female; Filaricides; Humans; Incidence; Ivermectin; Male; Middle Aged; Nigeria; Wuchereria bancrofti; Young Adult | 2011 |
Galactolipids from Bauhinia racemosa as a new class of antifilarial agents against human lymphatic filarial parasite, Brugia malayi.
Topics: Animals; Anthelmintics; Bauhinia; Brugia malayi; Diethylcarbamazine; Elephantiasis, Filarial; Filaricides; Galactolipids; Humans; Ivermectin; Plant Extracts; Plant Leaves | 2012 |
Evidence for stopping mass drug administration for lymphatic filariasis in some, but not all local government areas of Plateau and Nasarawa States, Nigeria.
Topics: Adolescent; Adult; Aged; Albendazole; Animals; Anthelmintics; Antigens, Helminth; Child; Child, Preschool; Cluster Analysis; Elephantiasis, Filarial; Female; Humans; Ivermectin; Male; Middle Aged; Nigeria; Prevalence; Rural Population; Wuchereria bancrofti; Young Adult | 2012 |
Maintaining effective mass drug administration for lymphatic filariasis through in-process monitoring in Sierra Leone.
Topics: Albendazole; Animals; Drug Utilization; Elephantiasis, Filarial; Female; Filaricides; Humans; Ivermectin; Male; Rural Population; Sierra Leone; Urban Population | 2012 |
Transmission assessment surveys in the Global Programme to Eliminate Lymphatic Filariasis: WHO position statement.
Topics: Albendazole; Elephantiasis, Filarial; Endemic Diseases; Filaricides; Global Health; Humans; Ivermectin; Prevalence; Preventive Health Services; Public Health Surveillance; World Health Organization | 2012 |
Soil transmitted helminths and scabies in Zanzibar, Tanzania following mass drug administration for lymphatic filariasis--a rapid assessment methodology to assess impact.
Topics: Adolescent; Adult; Albendazole; Animals; Antiparasitic Agents; Child; Child, Preschool; Drug Therapy, Combination; Elephantiasis, Filarial; Endemic Diseases; Helminthiasis; Humans; Infant; Intestinal Diseases, Parasitic; Ivermectin; Neglected Diseases; Onchocerciasis; Prevalence; Scabies; Soil; Tanzania; Young Adult | 2012 |
Major progress toward eliminating lymphatic filariasis.
Topics: Diethylcarbamazine; Drug Therapy, Combination; Elephantiasis, Filarial; Filaricides; Humans; Ivermectin | 2002 |
Cost-effectiveness of the use of vector control and mass drug administration, separately or in combination, against lymphatic filariasis.
Topics: Animals; Cost-Benefit Analysis; Culex; Diethylcarbamazine; Disease Vectors; Drug Therapy, Combination; Elephantiasis, Filarial; Endemic Diseases; Filaricides; Humans; India; Ivermectin; Mosquito Control; Rural Health; Wuchereria bancrofti | 2002 |
Use of floating layers of polystyrene beads to control populations of the filaria vector Culex quinquefasciatus.
Topics: Animals; Culex; Diethylcarbamazine; Disease Vectors; Elephantiasis, Filarial; Endemic Diseases; Filaricides; Humans; India; Ivermectin; Larva; Mosquito Control; Polystyrenes; Prevalence; Rural Health; Tanzania; Wuchereria bancrofti | 2002 |
Modelling the epidemiology, transmission and control of lymphatic filariasis.
Topics: Animals; Computer Simulation; Diethylcarbamazine; Drug Therapy, Combination; Elephantiasis, Filarial; Filaricides; Humans; Ivermectin; Models, Biological; Mosquito Control; Population Dynamics; Prevalence; Reproducibility of Results; Treatment Outcome; Wuchereria bancrofti | 2002 |
Report on active surveillance for adverse events following the use of drug co-administrations in the global programme to eliminate lymphatic filariasis.
Topics: Adverse Drug Reaction Reporting Systems; Albendazole; Animals; Diethylcarbamazine; Drug Therapy, Combination; Elephantiasis, Filarial; Filaricides; Global Health; Humans; International Cooperation; Ivermectin; Population Surveillance; Program Development; Wuchereria bancrofti | 2003 |
Prospects for elimination of bancroftian filariasis by mass drug treatment in Pondicherry, India: a simulation study.
Topics: Albendazole; Animals; Computer Simulation; Diethylcarbamazine; Elephantiasis, Filarial; Filaricides; Humans; India; Ivermectin; Models, Biological; Models, Statistical; Prevalence; Wuchereria bancrofti | 2003 |
Inadvertent exposure of pregnant women to ivermectin and albendazole during mass drug administration for lymphatic filariasis.
Topics: Abnormalities, Drug-Induced; Abortion, Spontaneous; Adolescent; Adult; Albendazole; Child Development; Contraindications; Drug Therapy, Combination; Elephantiasis, Filarial; Female; Filaricides; Focus Groups; Gestational Age; Humans; Infant; Infant, Newborn; Ivermectin; Male; Maternal-Fetal Exchange; Menstruation; Middle Aged; Patient Selection; Pregnancy; Pregnancy Complications, Infectious; Prenatal Exposure Delayed Effects; Risk Assessment | 2003 |
Report on the mid-term assessment of microfilaraemia reduction in sentinel sites of 13 countries of the Global Programme to Eliminate Lymphatic Filariasis.
Topics: Albendazole; Developing Countries; Diethylcarbamazine; Disease Outbreaks; Drug Therapy, Combination; Elephantiasis, Filarial; Filaricides; Global Health; Humans; Ivermectin; Prevalence; Sentinel Surveillance | 2004 |
Significant decrease in the prevalence of Wuchereria bancrofti infection in anopheline mosquitoes following the addition of albendazole to annual, ivermectin-based, mass treatments in Nigeria.
Topics: Albendazole; Animals; Anopheles; Anthelmintics; Culex; Culicidae; Drug Therapy, Combination; Elephantiasis, Filarial; Endemic Diseases; Epidemiologic Methods; Filaricides; Humans; Ivermectin; Nigeria; Rural Health | 2005 |
Pattern of community compliance with spaced, single-dose, mass administrations of diethylcarbamazine or ivermectin, for the elimination of lymphatic filariasis from rural areas of southern India.
Topics: Animals; Chi-Square Distribution; Cohort Studies; Diethylcarbamazine; Drug Administration Schedule; Elephantiasis, Filarial; Fever; Filaricides; Humans; India; Ivermectin; Nausea; Patient Compliance; Preventive Health Services; Program Evaluation; Rural Population; Wuchereria bancrofti | 2005 |
Global programme to eliminate lymphatic filariasis.
Topics: Albendazole; Anthelmintics; Developing Countries; Drug Therapy, Combination; Elephantiasis, Filarial; Global Health; Humans; Ivermectin; Treatment Outcome | 2005 |
Is anthelmintic resistance a threat to the program to eliminate lymphatic filariasis?
Topics: Albendazole; Animals; Anthelmintics; Diethylcarbamazine; Drug Resistance; Drug Therapy, Combination; Elephantiasis, Filarial; Humans; Ivermectin; Tubulin; Wuchereria bancrofti | 2005 |
Short communication: impact of long-term (14 years) bi-annual ivermectin treatment on Wuchereria bancrofti microfilaraemia.
Topics: Animals; Burkina Faso; Elephantiasis, Filarial; Endemic Diseases; Filaricides; Humans; Ivermectin; Mansonella; Mansonelliasis; Microfilariae; Onchocerciasis; Population Surveillance; Prevalence; Rural Health; Time Factors; Wuchereria bancrofti | 2005 |
Lost in translation.
Topics: Communicable Diseases; Developing Countries; Diffusion of Innovation; Drug Industry; Elephantiasis, Filarial; Humans; Ivermectin; Onchocerciasis | 2005 |
Elimination of transmission of lymphatic filariasis in Egypt.
Topics: Albendazole; Animals; Culex; Diethylcarbamazine; Disease Vectors; Egypt; Elephantiasis, Filarial; Filaricides; Humans; Ivermectin; Public Health; Wuchereria bancrofti | 2006 |
Successful integration of insecticide-treated bed net distribution with mass drug administration in Central Nigeria.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Albendazole; Animals; Antiparasitic Agents; Bedding and Linens; Child; Child, Preschool; Elephantiasis, Filarial; Female; Humans; Infant; Infant, Newborn; Insecticides; Ivermectin; Malaria; Male; Middle Aged; Mosquito Control; Nigeria | 2006 |
[A text-book case of tropical facial elephantiasis].
Topics: Adult; Antifungal Agents; Elephantiasis; Elephantiasis, Filarial; Face; Fatal Outcome; Filaricides; Humans; Ivermectin; Ketoconazole; Male; Superinfection; Zygomycosis | 2007 |
Vector control complements mass drug administration against bancroftian filariasis in Tirukoilur, India.
Topics: Adolescent; Adult; Albendazole; Animals; Antiparasitic Agents; Culex; Diethylcarbamazine; Elephantiasis, Filarial; Endemic Diseases; Humans; India; Insect Vectors; Ivermectin; Mosquito Control; Polystyrenes; Program Evaluation; Public Health Practice; Water Supply; Wuchereria bancrofti | 2007 |
Probability risk transmission matrix as a decision tool for assessing methods of transmission interruption of Wuchereria bancrofti infection.
Topics: Animals; Child, Preschool; Culex; Decision Support Techniques; Diethylcarbamazine; Elephantiasis, Filarial; Female; Filaricides; Housing; Humans; Incidence; India; Infant; Infant, Newborn; Insect Vectors; Ivermectin; Male; Prevalence; Risk Factors; Wuchereria bancrofti | 2008 |
Triple drug administration (TDA), with praziquantel, ivermectin and albendazole, for the prevention of three neglected tropical diseases in Nigeria.
Topics: Albendazole; Anthelmintics; Antiparasitic Agents; Cost-Benefit Analysis; Drug Interactions; Drug Therapy, Combination; Elephantiasis, Filarial; Female; Humans; Ivermectin; Male; Nigeria; Onchocerciasis; Praziquantel; Rural Health; Schistosomiasis | 2008 |
Impact of seven rounds of mass administration of diethylcarbamazine and ivermectin on prevalence of chronic lymphatic filariasis in south India.
Topics: Adult; Antiparasitic Agents; Community Health Services; Cross-Sectional Studies; Diethylcarbamazine; Elephantiasis, Filarial; Filaricides; Humans; India; Ivermectin; Male; Prevalence; Testicular Hydrocele | 2008 |
Lymphatic filariasis.
Topics: Adult; Antiparasitic Agents; Child; Diethylcarbamazine; Elephantiasis, Filarial; Female; Humans; Ivermectin; Loiasis; Male; Onchocerciasis, Ocular; Pregnancy | 2008 |
Ultrasonographic assessment of the adulticidal efficacy of repeat high-dose ivermectin in bancroftian filariasis.
Topics: Adult; Animals; Dose-Response Relationship, Drug; Drug Administration Schedule; Elephantiasis, Filarial; Humans; Ivermectin; Male; Middle Aged; Ultrasonography; Wuchereria bancrofti | 1996 |
Filarial antibody responses in Wuchereria bancrofti transmission area are related to parasitological but not clinical status.
Topics: Adult; Aged; Animals; Antibodies, Helminth; Diethylcarbamazine; Elephantiasis, Filarial; Female; Filaricides; Humans; Immunoglobulin Isotypes; Ivermectin; Male; Middle Aged; Wuchereria bancrofti | 1999 |
Mass treatment with ivermectin for filariasis control in Papua New Guinea: impact on mosquito survival.
Topics: Animals; Anopheles; Anthelmintics; Elephantiasis, Filarial; Female; Humans; Insect Vectors; Ivermectin; Mosquito Control; Papua New Guinea; Wuchereria bancrofti | 1999 |
At last, the fight against lymphatic filiariasis begins.
Topics: Albendazole; Anthelmintics; Elephantiasis, Filarial; Humans; International Cooperation; Ivermectin | 2000 |
Elimination of lymphatic filariasis as a public health problem.
Topics: Albendazole; Animals; Elephantiasis, Filarial; Filaricides; Humans; Ivermectin; Program Development; Public Health | 2000 |
Community-directed treatment: the way forward to eliminating lymphatic filariasis as a public-health problem in Ghana.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Community Health Services; Elephantiasis, Filarial; Endemic Diseases; Female; Filaricides; Ghana; Humans; Ivermectin; Male; Medication Systems; Middle Aged; Outcome and Process Assessment, Health Care; Patient Compliance; Patient Participation | 2001 |
Early-stage elephantiasis in bancroftian filariasis.
Topics: Adult; Albendazole; Animals; Developing Countries; Drug Therapy, Combination; Elephantiasis, Filarial; Endemic Diseases; Filaricides; Follow-Up Studies; Humans; Ivermectin; Male; Risk Assessment; Severity of Illness Index; South Africa; Travel; Treatment Outcome; Wuchereria bancrofti | 2001 |
Filariasis elimination, Zanzibar.
Topics: Albendazole; Drug Therapy, Combination; Elephantiasis, Filarial; Female; Filaricides; Humans; Ivermectin; Male; National Health Programs; Tanzania | 2001 |
Quantification of PCR amplification products of Brugia HhaI repeat DNA using a semiautomated Q-PCR system.
Topics: Animals; Automation; Brugia; Cytokines; Deoxyribonucleases, Type II Site-Specific; DNA Primers; DNA, Helminth; Elephantiasis, Filarial; Filaricides; Ivermectin; Luminescent Measurements; Lymph Nodes; Male; Polymerase Chain Reaction; Repetitive Sequences, Nucleic Acid; Sensitivity and Specificity; Spleen | 2002 |
Results of a safety trial on single-dose treatments with 400 mcg/kg of ivermectin in bancroftian filariasis.
Topics: Adult; Aged; Aged, 80 and over; Animals; Carrier State; Dose-Response Relationship, Drug; Drug Tolerance; Elephantiasis, Filarial; Female; Humans; Ivermectin; Male; Microfilariae; Middle Aged; Sex Factors; Wuchereria bancrofti | 1992 |
Efficacy of ivermectin for control of microfilaremia recurring after treatment with diethylcarbamazine. II. Immunologic changes following treatment.
Topics: Adolescent; Adult; Animals; Antibodies, Helminth; Antigens, Helminth; Diethylcarbamazine; Elephantiasis, Filarial; Female; Humans; Hypersensitivity, Immediate; Interleukins; Ivermectin; Male; Microfilariae; Middle Aged; Tumor Necrosis Factor-alpha; Wuchereria bancrofti | 1991 |
Changes in circulating parasite antigen levels after treatment of bancroftian filariasis with diethylcarbamazine and ivermectin.
Topics: Animals; Antigens, Helminth; Diethylcarbamazine; Elephantiasis, Filarial; Humans; Ivermectin; Microfilariae; Wuchereria bancrofti | 1991 |
Bancroftian filariasis and ivermectin.
Topics: Animals; Diethylcarbamazine; Elephantiasis, Filarial; Filariasis; Humans; Ivermectin; Male; Wuchereria bancrofti | 1990 |
Brugia malayi and Brugia pahangi: transmission blocking activity of ivermectin and brugian filarial infections in Aedes aegypti.
Topics: Aedes; Animals; Brugia; Elephantiasis, Filarial; Female; Gerbillinae; Insect Vectors; Ivermectin; Larva; Lectins; Male; Microfilariae | 1990 |
Effect of ivermectin on filariae of Mastomys natalensis.
Topics: Animals; Brugia; Dipetalonema; Dipetalonema Infections; Elephantiasis, Filarial; Female; Filariasis; Filarioidea; Ivermectin; Microfilariae; Muridae | 1990 |
Ivermectin in lymphatic filariasis.
Topics: Animals; Dog Diseases; Dogs; Elephantiasis, Filarial; Humans; Ivermectin | 1990 |
Ivermectin and prothrombin time.
Topics: Administration, Oral; Adult; Animals; Diethylcarbamazine; Elephantiasis, Filarial; Filariasis; Humans; Ivermectin; Prothrombin Time; Wuchereria bancrofti | 1989 |
[A study of ivermectin in the treatment of lymphatic filariasis due to Wuchereria bancrofti var. pacifica in French Polynesia].
Topics: Adult; Animals; Carrier State; Elephantiasis, Filarial; Filariasis; Humans; Ivermectin; Male; Polynesia; Wuchereria | 1989 |
Lymphatic filariasis: some recent trends and advances.
Topics: Animals; Brugia; Culex; Elephantiasis, Filarial; Filariasis; Insect Vectors; Ivermectin; Sri Lanka; Wuchereria bancrofti | 1988 |
Ivermectin for the treatment of Wuchereria bancrofti filariasis. Efficacy and adverse reactions.
Topics: Adult; Animals; Dose-Response Relationship, Drug; Elephantiasis, Filarial; Filariasis; Humans; Hypotension, Orthostatic; India; Ivermectin; Male; Middle Aged; Recurrence; Wuchereria bancrofti | 1988 |
Effect of ivermectin against subperiodic Brugia malayi infection in the leaf monkey, Presbytis cristata.
Topics: Administration, Oral; Animals; Brugia; Cercopithecidae; Elephantiasis, Filarial; Filariasis; Injections, Subcutaneous; Ivermectin | 1988 |
Chemoprophylactic studies with ivermectin against subperiodic Brugia malayi infection in the leaf monkey, Presbytis cristata.
Topics: Animals; Brugia; Cercopithecidae; Elephantiasis, Filarial; Female; Filariasis; Ivermectin; Male; Random Allocation | 1987 |